Substrates for peptidase C02.002: calpain-2
Peptide and protein substrates that are thought to be physiologically relevant are indicated by P. Peptide and protein substrates that are thought to be pathologically relevant are indicated by D. Peptide and protein substrates that are not physiologically relevant are indicated by N. Synthetic substrates are indicated by S. Click on the symbol to show only physiological, non-physiological or synthetic substrates, or here to display all substrates. How cleavage sites have been identified are indicated by the following evidence codes: NT = N-terminal sequencing, MS = mass spectroscopy, MU = mutation, CS = consensus sequence, LC = liquid chromatography. To see all annotated cleavages for a protein substrate, click on the UniProt Accession.
| Substrate | Uniprot | Residue range | Cleavage Site | Cleavage type | Evidence | P4 | P3 | P2 | P1 | P1' | P2' | P3' | P4' | Reference | CutDB | MERNUM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 | Q9NQ66 | 872-890 | Pro-Lys-Pro-Pro-Ser-Gln-Ala-Leu-His+Ser-Gln-Pro-Ala-Pro-Gly-Ser-Val-Lys-Ala | P | MS | Gln | Ala | Leu | His | Ser | Gln | Pro | Ala | Shinkai-Ouchi et al., 2016 | ||
| 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 | Q9NQ66 | 871-890 | Thr-Pro-Lys-Pro-Pro-Ser-Gln-Ala-Leu-His-Ser-Gln-Pro-Ala-Pro-Gly-Ser-Val-Lys+Ala | P | MS | Gly | Ser | Val | Lys | Ala | '-' | '-' | '-' | Shinkai-Ouchi et al., 2016 | ||
| 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 | Q9NQ66 | 871-890 | Thr-Pro-Lys-Pro-Pro-Ser-Gln-Ala-Leu-His-Ser-Gln-Pro-Ala+Pro-Gly-Ser-Val-Lys-Ala | P | MS | Ser | Gln | Pro | Ala | Pro | Gly | Ser | Val | Shinkai-Ouchi et al., 2016 | ||
| 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 | Q9NQ66 | 871-890 | Thr-Pro-Lys-Pro-Pro-Ser-Gln-Ala-Leu-His-Ser-Gln+Pro-Ala-Pro-Gly-Ser-Val-Lys-Ala | P | MS | Leu | His | Ser | Gln | Pro | Ala | Pro | Gly | Shinkai-Ouchi et al., 2016 | ||
| 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 | Q9NQ66 | 871-890 | Thr-Pro-Lys-Pro-Pro-Ser-Gln-Ala-Leu-His-Ser+Gln-Pro-Ala-Pro-Gly-Ser-Val-Lys-Ala | P | MS | Ala | Leu | His | Ser | Gln | Pro | Ala | Pro | Shinkai-Ouchi et al., 2016 | ||
| 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 | Q9NQ66 | 871-890 | Thr-Pro-Lys-Pro-Pro-Ser-Gln-Ala-Leu-His+Ser-Gln-Pro-Ala-Pro-Gly-Ser-Val-Lys-Ala | P | MS | Gln | Ala | Leu | His | Ser | Gln | Pro | Ala | Shinkai-Ouchi et al., 2016 | ||
| 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-1 | P10894 | 1-1216 | peptide-His880+Ser-peptide | P | Gln | Ala | Leu | His | Ser | Gln | Pro | Ala | Park et al., 1993 | 26490 | ||
| 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-1 | P10894 | 1-1216 | peptide-Pro1208+Gly-peptide | P | Gly | Glu | Asn | Pro | Gly | Lys | Glu | Phe | Park et al., 1993 | 26491 | ||
| actin, cytoplasmic 1 | P60709 | 28-47 | Arg-Ala-Val-Phe-Pro-Ser-Ile-Val-Gly-Arg-Pro-Arg-His-Gln-Gly-Val-Met+Val-Gly-Met | P | MS | Gln | Gly | Val | Met | Val | Gly | Met | '-' | Shinkai-Ouchi et al., 2016 | ||
| actin, cytoplasmic 1 | P60709 | 28-47 | Arg-Ala-Val-Phe-Pro-Ser-Ile-Val-Gly-Arg-Pro-Arg-His-Gln+Gly-Val-Met-Val-Gly-Met | P | MS | Pro | Arg | His | Gln | Gly | Val | Met | Val | Shinkai-Ouchi et al., 2016 | ||
| actin, cytoplasmic 1 | P60709 | 28-47 | Arg-Ala-Val-Phe-Pro-Ser-Ile-Val-Gly-Arg-Pro-Arg-His+Gln-Gly-Val-Met-Val-Gly-Met | P | MS | Arg | Pro | Arg | His | Gln | Gly | Val | Met | Shinkai-Ouchi et al., 2016 | ||
| actin, cytoplasmic 1 | P60709 | 28-47 | Arg-Ala-Val-Phe-Pro-Ser-Ile-Val-Gly+Arg-Pro-Arg-His-Gln-Gly-Val-Met-Val-Gly-Met | P | MS | Ser | Ile | Val | Gly | Arg | Pro | Arg | His | Shinkai-Ouchi et al., 2016 | ||
| aggrecan core protein | P13608 | 17-2364 | peptide-Gly365+Gly-peptide | P | NT | Phe | Gly | Val | Gly | Gly | Glu | Glu | Asp | Oshita et al., 2004 | 23869 | |
| aggrecan core protein | P13608 | 17-2364 | peptide-Ala719+Ala-peptide | P | NT | Pro | Gly | Val | Ala | Ala | Val | Pro | Ile | Oshita et al., 2004 | 23871 | |
| aggrecan core protein | P13608 | 17-2364 | peptide-Ser1229+Val-peptide | P | NT | Glu | Asp | Leu | Ser | Val | Leu | Pro | Ser | Oshita et al., 2004 | 23872 | |
| aggrecan core protein | P13608 | 17-2364 | peptide-Gly1307+Val-peptide | P | NT | Glu | Asp | Leu | Gly | Val | Leu | Pro | Ser | Oshita et al., 2004 | 23875 | |
| aggrecan core protein | P13608 | 17-2364 | peptide-Ser1249+Val-peptide | P | NT | Glu | Asp | Leu | Ser | Val | Leu | Pro | Ser | Oshita et al., 2004 | ||
| aggrecan core protein | P13608 | 17-2364 | peptide-Ser1287+Val-peptide | P | NT | Glu | Asp | Leu | Ser | Val | Leu | Pro | Ser | Oshita et al., 2004 | ||
| aggrecan core protein | P13608 | 17-2364 | peptide-Ser1346+Val-peptide | P | NT | Glu | Asp | Leu | Ser | Val | Leu | Pro | Ser | Oshita et al., 2004 | ||
| aggrecan core protein | P13608 | 17-2364 | peptide-Ala474+Ala-peptide | P | NT | Ala | Pro | Gly | Ala | Ala | Glu | Val | Pro | Oshita et al., 2004 | 23870 | |
| Alpha-actinin-1 | P05094 | 1-893 | Peptide-Tyr247+His-Peptide | P | NT | Ser | Ser | Phe | Tyr | His | Ala | Phe | Ser | Sprague et al., 2008 | ||
| Alpha-actinin-1 | P05094 | 1-893 | Peptide-Ser244+Ser-Peptide | P | NT | Thr | Tyr | Val | Ser | Ser | Phe | Tyr | His | Sprague et al., 2008 | ||
| alpha-synuclein | P37840 | 48-67 | Val-Val-His-Gly-Val-Ala-Thr-Val-Ala-Glu-Lys-Thr-Lys+Glu-Gln-Val-Thr-Asn-Val-Gly | P | MS | Glu | Lys | Thr | Lys | Glu | Gln | Val | Thr | Shinkai-Ouchi et al., 2016 | ||
| alpha-synuclein | P37840 | 48-67 | Val-Val-His-Gly-Val-Ala-Thr-Val-Ala-Glu+Lys-Thr-Lys-Glu-Gln-Val-Thr-Asn-Val-Gly | P | MS | Thr | Val | Ala | Glu | Lys | Thr | Lys | Glu | Shinkai-Ouchi et al., 2016 | ||
| AMPH amphiphysin isoform 1 | P49418 | 1-695 | peptide-Ser333+Val-peptide | P | Pro | Glu | Ile | Ser | Val | Thr | Thr | Pro | Wu et al., 2007 | 21718 | ||
| AMPH amphiphysin isoform 1 | P49418 | 1-695 | peptide-Ser377+Gln-peptide | P | Ser | Pro | Met | Ser | Gln | Thr | Leu | Pro | Wu et al., 2007 | 22622 | ||
| AMPH amphiphysin isoform 1 | P49418 | 1-695 | peptide-Val392+Gln-peptide | P | Thr | Asp | Leu | Val | Gln | Pro | Ala | Ser | Wu et al., 2007 | 22623 | ||
| AMPH amphiphysin isoform 1 | P49418 | 1-695 | peptide-Met454+Asp-peptide | P | Asp | Leu | Gly | Met | Asp | Thr | Arg | Ala | Wu et al., 2007 | 22624 | ||
| AMPH amphiphysin isoform 1 | P49418 | 1-695 | peptide-Gly478+Thr-peptide | P | Ala | Ala | Val | Gly | Thr | Leu | Val | Ser | Wu et al., 2007 | 22625 | ||
| AMPH amphiphysin isoform 1 | P49418 | 1-695 | peptide-Ala527+Glu-peptide | P | Gln | Pro | Glu | Ala | Glu | Glu | Leu | Glu | Wu et al., 2007 | 22626 | ||
| AMPH amphiphysin isoform 1 | P49418 | 1-695 | peptide-Glu531+Ala-peptide | P | Glu | Glu | Leu | Glu | Ala | Thr | Val | Pro | Wu et al., 2007 | 22627 | ||
| AMPH amphiphysin isoform 1 | P49418 | 1-695 | peptide-Asp593+Pro-peptide | P | Pro | Ile | Gln | Asp | Pro | Gln | Pro | Thr | Wu et al., 2007 | 22628 | ||
| AMPH amphiphysin isoform 1 | P49418 | 1-695 | peptide-Leu609+Ala-peptide | P | Ala | Asp | Gln | Leu | Ala | Ser | Ala | Arg | Wu et al., 2007 | 22629 | ||
| angiotensinogen | P01015 | 20-39 | Ser-Leu-Thr-Ala-Gly-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Tyr+Tyr-Ser-Lys | P | MS | His | Leu | Leu | Tyr | Tyr | Ser | Lys | '-' | Shinkai-Ouchi et al., 2016 | ||
| angiotensinogen | P01015 | 19-39 | Val-Ser-Leu-Thr-Ala-Gly-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu+Tyr-peptide | P | MS | His | Leu | Leu | Tyr | Tyr | Ser | Lys | '-' | Shinkai-Ouchi et al., 2016 | ||
| angiotensinogen | P01015 | 19-39 | peptide-Leu35+Tyr-peptide | P | MS | Phe | His | Leu | Leu | Tyr | Tyr | Ser | Lys | Shinkai-Ouchi et al., 2016 | ||
| angiotensinogen | P01015 | 19-39 | peptide-His33+Leu-peptide | P | MS | His | Pro | Phe | His | Leu | Leu | Tyr | Tyr | Shinkai-Ouchi et al., 2016 | ||
| annexin A1 | P04083 | 17-36 | Glu-Glu-Gln-Glu-Tyr-Val-Gln-Thr-Val-Lys-Ser-Ser+Lys-Gly-Gly-Pro-Gly-Ser-Ala-Val | P | MS | Val | Lys | Ser | Ser | Lys | Gly | Gly | Pro | Shinkai-Ouchi et al., 2016 | ||
| annexin A1 | P04083 | 17-36 | Glu-Glu-Gln-Glu-Tyr-Val-Gln-Thr-Val-Lys-Ser+Ser-Lys-Gly-Gly-Pro-Gly-Ser-Ala-Val | P | MS | Thr | Val | Lys | Ser | Ser | Lys | Gly | Gly | Shinkai-Ouchi et al., 2016 | ||
| annexin A1 | P04083 | 17-36 | Glu-Glu-Gln-Glu-Tyr-Val-Gln-Thr-Val-Lys+Ser-Ser-Lys-Gly-Gly-Pro-Gly-Ser-Ala-Val | P | MS | Gln | Thr | Val | Lys | Ser | Ser | Lys | Gly | Shinkai-Ouchi et al., 2016 | ||
| annexin A1 | P04083 | 18-36 | Glu-Gln-Glu-Tyr-Val-Gln-Thr-Val-Lys+Ser-Ser-Lys-Gly-Gly-Pro-Gly-Ser-Ala-Val | P | MS | Gln | Thr | Val | Lys | Ser | Ser | Lys | Gly | Shinkai-Ouchi et al., 2016 | ||
| annexin A1 | P04083 | 20-36 | Glu-Tyr-Val-Gln-Thr-Val-Lys+Ser-Ser-Lys-Gly-Gly-Pro-Gly-Ser-Ala-Val | P | MS | Gln | Thr | Val | Lys | Ser | Ser | Lys | Gly | Shinkai-Ouchi et al., 2016 | ||
| AP-2 complex subunit beta | P62944-2 | 1-937 | peptide-Phe691+Ala-peptide | P | NT | Pro | Ala | Thr | Phe | Ala | Pro | Ser | Pro | Rudinskiy et al., 2009 | ||
| apoptosis regulator BAX | Q07812 | 19-38 | Ile-Met-Lys-Thr-Gly-Ala-Leu-Leu-Leu-Gln-Gly-Phe-Ile-Gln-Asp-Arg-Ala+Gly-Arg-Met | P | MS | Gln | Asp | Arg | Ala | Gly | Arg | Met | '-' | Shinkai-Ouchi et al., 2016 | ||
| apoptosis regulator BAX | Q07812 | 19-38 | Ile-Met-Lys-Thr-Gly-Ala-Leu-Leu-Leu-Gln-Gly-Phe-Ile-Gln-Asp-Arg+Ala-Gly-Arg-Met | P | MS | Ile | Gln | Asp | Arg | Ala | Gly | Arg | Met | Shinkai-Ouchi et al., 2016 | ||
| apoptosis regulator BAX | Q07812 | 19-38 | Ile-Met-Lys-Thr-Gly-Ala-Leu-Leu-Leu-Gln-Gly+Phe-Ile-Gln-Asp-Arg-Ala-Gly-Arg-Met | P | MS | Leu | Leu | Gln | Gly | Phe | Ile | Gln | Asp | Shinkai-Ouchi et al., 2016 | ||
| apoptosis regulator BAX | Q07812 | 19-38 | Ile-Met-Lys-Thr-Gly-Ala-Leu-Leu-Leu-Gln+Gly-Phe-Ile-Gln-Asp-Arg-Ala-Gly-Arg-Met | P | MS | Leu | Leu | Leu | Gln | Gly | Phe | Ile | Gln | Shinkai-Ouchi et al., 2016 | ||
| apoptosis regulator BAX | Q07812 | 19-38 | Ile-Met-Lys-Thr-Gly-Ala-Leu-Leu-Leu+Gln-Gly-Phe-Ile-Gln-Asp-Arg-Ala-Gly-Arg-Met | P | MS | Ala | Leu | Leu | Leu | Gln | Gly | Phe | Ile | Shinkai-Ouchi et al., 2016 | ||
| apoptosis regulator BAX | Q07812 | 19-38 | Ile-Met-Lys+Thr-Gly-Ala-Leu-Leu-Leu-Gln-Gly-Phe-Ile-Gln-Asp-Arg-Ala-Gly-Arg-Met | P | MS | '-' | Ile | Met | Lys | Thr | Gly | Ala | Leu | Shinkai-Ouchi et al., 2016 | ||
| apoptosis regulator Bcl-X | Q64373 | 1-233 | peptide-Ala60+Asp-peptide | P | Trp | His | Leu | Ala | Asp | Ser | Pro | Ala | Nakagawa & Yuan, 2000 | 19270 | ||
| beta crystallin A3 | P11843 | 1-215 | peptide-Glu11+Ser-peptide | P | Gln | Glu | Leu | Glu | Ser | Leu | Pro | Thr | Shih et al., 1998 | |||
| beta crystallin A3 | P11843 | 1-215 | peptide-Lys17+Met-peptide | P | Pro | Thr | Thr | Lys | Met | Ala | Gln | Thr | Shih et al., 1998 | |||
| beta crystallin A3 | P11843 | 1-215 | peptide-Asn22+Pro-peptide | P | Ala | Gln | Thr | Asn | Pro | Met | Pro | Gly | Shih et al., 1998 | |||
| beta crystallin A3 | P14881 | 1-215 | peptide-Glu11+Thr-peptide | P | Arg | Glu | Leu | Glu | Thr | Leu | Pro | Thr | David et al., 1994 | 19752 | ||
| beta crystallin B1 | P07318 | 2-253 | peptide-Ala12+Ala-peptide | P | Ser | Ala | Thr | Ala | Ala | Val | Asn | Pro | Shih et al., 1998 | |||
| beta crystallin B1 | P07318 | 2-253 | peptide-Asn14+Pro-peptide | P | Ala | Ala | Val | Asn | Pro | Gly | Pro | Asp | Shih et al., 1998 | |||
| beta crystallin B1 | P02523 | 2-250 | peptide-Gly28+Thr-peptide | P | Pro | Ser | Thr | Gly | Thr | Ala | Pro | Ala | David et al., 1994 | 19746 | ||
| beta crystallin B1 | P02523 | 2-250 | peptide-Gly50+Glu-peptide | P | Ala | Lys | Val | Gly | Glu | Leu | Pro | Pro | David et al., 1994 | 19747 | ||
| beta crystallin B1 | P02523 | 2-250 | peptide-Ala30+Pro-peptide | P | Thr | Gly | Thr | Ala | Pro | Ala | Pro | Gly | David et al., 1994 | |||
| beta crystallin B1 | P02523 | 2-250 | peptide-Ser41+Val-peptide | P | Val | Pro | Ala | Ser | Val | Pro | Arg | Pro | David et al., 1994 | |||
| beta crystallin B1 | P02523 | 2-250 | peptide-Ala46+Ala-peptide | P | Pro | Arg | Pro | Ala | Ala | Lys | Val | Gly | David et al., 1994 | |||
| beta crystallin B2 | P02522 | 2-205 | peptide-Gln7+Ala-peptide | P | His | Gln | Thr | Gln | Ala | Gly | Lys | Pro | Shih et al., 1998 | |||
| beta crystallin B3 | P19141 | 2-211 | peptide-Gln9+Ala-peptide | P | Thr | Pro | Glu | Gln | Ala | Ala | Ala | Gly | Shih et al., 1998 | |||
| beta crystallin B3 | P19141 | 2-211 | peptide-His5+Ser-peptide | P | Ala | Glu | Gln | His | Ser | Thr | Pro | Glu | Shih et al., 1998 | |||
| beta crystallin B3 | P02524 | 2-211 | peptide-Gln4+His-peptide | P | Met | Ala | Glu | Gln | His | Gly | Ala | Pro | David et al., 1994 | 19748 | ||
| beta crystallin B3 | P02524 | 2-211 | peptide-His5+Gly-peptide | P | Ala | Glu | Gln | His | Gly | Ala | Pro | Glu | David et al., 1994 | 19749 | ||
| beta crystallin B3 | P02524 | 2-211 | peptide-His17+Gly-peptide | P | Ser | Lys | Ser | His | Gly | Gly | Leu | Gly | David et al., 1994 | 19751 | ||
| beta crystallin B3 | P02524 | 2-211 | peptide-Gln10+Ala-peptide | P | Ala | Pro | Glu | Gln | Ala | Ala | Ala | Ser | David et al., 1994 | 19750 | ||
| bH3-interacting domain death agonist | P55957 | 61-80 | Gly-Asn-Arg-Ser-Ser-His-Ser-Arg-Leu-Gly+Arg-Ile-Glu-Ala-Asp-Ser-Glu-Ser-Gln-Glu | P | MS | Ser | Arg | Leu | Gly | Arg | Ile | Glu | Ala | Shinkai-Ouchi et al., 2016 | ||
| calcium/calmodulin-dependent protein kinase type IV | P08414 | 1-469 | peptide-Gly199+Thr-peptide | P | Thr | Val | Cys | Gly | Thr | Pro | Gly | Tyr | McGinnis et al., 1998 | |||
| calcium/calmodulin-dependent protein kinase type IV | P08414 | 1-469 | peptide-Asn23+Leu-peptide | P | Ser | Thr | Glu | Asn | Leu | Val | Pro | Asp | McGinnis et al., 1998 | |||
| calpain-1 catalytic subunit | P07384 | 6-25 | Ile-Thr-Pro-Val-Tyr-Cys-Thr-Gly-Val-Ser-Ala-Gln-Val-Gln-Lys+Gln-Arg-Ala-Arg-Glu | P | MS | Gln | Val | Gln | Lys | Gln | Arg | Ala | Arg | Shinkai-Ouchi et al., 2016 | ||
| calpain-1 catalytic subunit | P07384 | 6-25 | Ile-Thr-Pro-Val-Tyr-Cys-Thr-Gly-Val-Ser-Ala-Gln-Val-Gln+Lys-Gln-Arg-Ala-Arg-Glu | P | MS | Ala | Gln | Val | Gln | Lys | Gln | Arg | Ala | Shinkai-Ouchi et al., 2016 | ||
| calpain-1 catalytic subunit | P07384 | 6-25 | Ile-Thr-Pro-Val-Tyr-Cys-Thr-Gly-Val-Ser+Ala-Gln-Val-Gln-Lys-Gln-Arg-Ala-Arg-Glu | P | MS | Thr | Gly | Val | Ser | Ala | Gln | Val | Gln | Shinkai-Ouchi et al., 2016 | ||
| calpain-1 catalytic subunit | P07384 | 6-25 | Ile-Thr-Pro-Val-Tyr-Cys-Thr-Gly-Val+Ser-Ala-Gln-Val-Gln-Lys-Gln-Arg-Ala-Arg-Glu | P | MS | Cys | Thr | Gly | Val | Ser | Ala | Gln | Val | Shinkai-Ouchi et al., 2016 | ||
| calpain-1 catalytic subunit | P07384 | 6-25 | Ile-Thr-Pro-Val-Tyr-Cys-Thr-Gly+Val-Ser-Ala-Gln-Val-Gln-Lys-Gln-Arg-Ala-Arg-Glu | P | MS | Tyr | Cys | Thr | Gly | Val | Ser | Ala | Gln | Shinkai-Ouchi et al., 2016 | ||
| calpain-1 catalytic subunit | P07384 | 6-25 | Ile-Thr-Pro-Val-Tyr-Cys+Thr-Gly-Val-Ser-Ala-Gln-Val-Gln-Lys-Gln-Arg-Ala-Arg-Glu | P | MS | Pro | Val | Tyr | Cys | Thr | Gly | Val | Ser | Shinkai-Ouchi et al., 2016 | ||
| calpain-1 catalytic subunit | P07384 | 6-25 | Ile-Thr+Pro-Val-Tyr-Cys-Thr-Gly-Val-Ser-Ala-Gln-Val-Gln-Lys-Gln-Arg-Ala-Arg-Glu | P | MS | '-' | '-' | Ile | Thr | Pro | Val | Tyr | Cys | Shinkai-Ouchi et al., 2016 | ||
| calpain-1 catalytic subunit | P07384 | 17-37 | peptide-Gly29+Arg-peptide | P | MS | Leu | Gly | Leu | Gly | Arg | His | Glu | Asn | Shinkai-Ouchi et al., 2016 | ||
| calpain-1 catalytic subunit | P07384 | 17-37 | peptide-Gly27+Leu-peptide | P | MS | Arg | Glu | Leu | Gly | Leu | Gly | Arg | His | Shinkai-Ouchi et al., 2016 | ||
| calpain-2 catalytic subunit | P17655 | 2-700 | peptide-Ala9+Lys-peptide | P | Ala | Lys | Leu | Ala | Lys | Asp | Arg | Glu | Brown & Crawford, 1993 | |||
| calpain-2 catalytic subunit | P17655 | 2-700 | peptide-Gly18+Ser-peptide | P | Glu | Gly | Leu | Gly | Ser | His | Asp | Arg | Brown & Crawford, 1993 | |||
| caspase-12 precursor | O08736 | 1-419 | peptide-Thr132+Ala-peptide | P | Leu | Met | Leu | Thr | Ala | Pro | His | Gly | Nakagawa & Yuan, 2000 | 19268 | ||
| caspase-12 precursor | O08736 | 1-419 | peptide-Lys158+Thr-peptide | P | Cys | Lys | Ile | Lys | Thr | Glu | Arg | Ala | Nakagawa & Yuan, 2000 | 19269 | ||
| caspase-9 | P55211 | 106-125 | Leu-Thr-Pro-Val-Val-Leu-Arg-Pro-Glu-Ile-Arg-Lys-Pro-Glu-Val+Leu-Arg-Pro-Glu-Thr | P | MS | Lys | Pro | Glu | Val | Leu | Arg | Pro | Glu | Shinkai-Ouchi et al., 2016 | ||
| caspase-9 | P55211 | 106-125 | Leu-Thr-Pro-Val-Val-Leu-Arg-Pro-Glu-Ile+Arg-Lys-Pro-Glu-Val-Leu-Arg-Pro-Glu-Thr | P | MS | Arg | Pro | Glu | Ile | Arg | Lys | Pro | Glu | Shinkai-Ouchi et al., 2016 | ||
| caspase-9 precursor | P55211 | 1-416 | peptide-Ile115+Arg-peptide | P | Arg | Pro | Glu | Ile | Arg | Lys | Pro | Glu | Chua et al., 2000 | 26480 | ||
| caspase-9 precursor | P55211 | 1-416 | peptide-Asp330+Ala-peptide | P | Asp | Gln | Leu | Asp | Ala | Ile | Ser | Ser | Chua et al., 2000 | 26478 | ||
| cellular tumor antigen p53 | P04637 | 17-35 | Glu-Thr-Phe-Ser-Asp-Leu-Trp-Lys-Leu-Leu-Pro-Glu-Asn-Asn+Val-Leu-Ser-Pro-Leu | P | MS | Pro | Glu | Asn | Asn | Val | Leu | Ser | Pro | Shinkai-Ouchi et al., 2016 | ||
| cellular tumor antigen p53 | P04637 | 16-35 | Gln-Glu-Thr-Phe-Ser-Asp-Leu-Trp-Lys-Leu-Leu-Pro-Glu-Asn-Asn+Val-Leu-Ser-Pro-Leu | P | MS | Pro | Glu | Asn | Asn | Val | Leu | Ser | Pro | Shinkai-Ouchi et al., 2016 | ||
| cellular tumor antigen p53 | P04637 | 16-35 | Gln-Glu-Thr-Phe-Ser-Asp-Leu-Trp-Lys-Leu+Leu-Pro-Glu-Asn-Asn-Val-Leu-Ser-Pro-Leu | P | MS | Leu | Trp | Lys | Leu | Leu | Pro | Glu | Asn | Shinkai-Ouchi et al., 2016 | ||
| cellular tumor antigen p53 | P04637 | 16-35 | Gln-Glu-Thr-Phe-Ser-Asp-Leu-Trp+Lys-Leu-Leu-Pro-Glu-Asn-Asn-Val-Leu-Ser-Pro-Leu | P | MS | Ser | Asp | Leu | Trp | Lys | Leu | Leu | Pro | Shinkai-Ouchi et al., 2016 | ||
| cellular tumor antigen p53 | P04637 | 16-35 | Gln-Glu-Thr-Phe+Ser-Asp-Leu-Trp-Lys-Leu-Leu-Pro-Glu-Asn-Asn-Val-Leu-Ser-Pro-Leu | P | MS | Gln | Glu | Thr | Phe | Ser | Asp | Leu | Trp | Shinkai-Ouchi et al., 2016 | ||
| Cholecystokinin-8 | P06307 | 96-103 | Peptide-Phe103+NH2 | N | Trp | Met | Asp | Phe | NH2 | - | - | - | McDermott et al., 1985 | |||
| Choline-phosphate cytidylyltransferase A | P19836 | 1-367 | Peptide-Asn236+Glu-Peptide | P | NT | Ser | Phe | Ile | Asn | Glu | Lys | Lys | Tyr | Zhou et al., 2003 | ||
| coatomer subunit beta | P53618 | 519-538 | Gly-Thr-Tyr-Ala-Thr-Gln-Ser-Ala-Leu-Ser-Ser+Ser-Arg-Pro-Thr-Lys-Lys-Glu-Glu-Asp | P | MS | Ala | Leu | Ser | Ser | Ser | Arg | Pro | Thr | Shinkai-Ouchi et al., 2016 | ||
| coatomer subunit beta | P53618 | 519-538 | Gly-Thr-Tyr-Ala-Thr-Gln-Ser-Ala-Leu-Ser+Ser-Ser-Arg-Pro-Thr-Lys-Lys-Glu-Glu-Asp | P | MS | Ser | Ala | Leu | Ser | Ser | Ser | Arg | Pro | Shinkai-Ouchi et al., 2016 | ||
| coatomer subunit beta | P53618 | 519-538 | Gly-Thr-Tyr+Ala-Thr-Gln-Ser-Ala-Leu-Ser-Ser-Ser-Arg-Pro-Thr-Lys-Lys-Glu-Glu-Asp | P | MS | '-' | Gly | Thr | Tyr | Ala | Thr | Gln | Ser | Shinkai-Ouchi et al., 2016 | ||
| cyclin-dependent kinase 4 inhibitor D | P55273 | 20-39 | Asp-Val-Gln-Glu-Val-Arg-Arg-Leu-Leu-His-Arg-Glu-Leu-Val-His-Pro-Asp-Ala+Leu-Asn | P | MS | His | Pro | Asp | Ala | Leu | Asn | '-' | '-' | Shinkai-Ouchi et al., 2016 | ||
| cyclin-dependent kinase 4 inhibitor D | P55273 | 20-39 | Asp-Val-Gln-Glu-Val-Arg-Arg-Leu-Leu-His-Arg-Glu-Leu+Val-His-Pro-Asp-Ala-Leu-Asn | P | MS | His | Arg | Glu | Leu | Val | His | Pro | Asp | Shinkai-Ouchi et al., 2016 | ||
| cyclin-dependent kinase 4 inhibitor D | P55273 | 20-39 | Asp-Val-Gln-Glu-Val-Arg-Arg-Leu-Leu-His+Arg-Glu-Leu-Val-His-Pro-Asp-Ala-Leu-Asn | P | MS | Arg | Leu | Leu | His | Arg | Glu | Leu | Val | Shinkai-Ouchi et al., 2016 | ||
| cyclin-dependent kinase 4 inhibitor D | P55273 | 55-74 | Ala-Ile-Ala-Leu-Glu-Leu-Leu-Lys-Gln-Gly-Ala-Ser-Pro-Asn-Val-Gln+Asp-Thr-Ser-Gly | P | MS | Pro | Asn | Val | Gln | Asp | Thr | Ser | Gly | Shinkai-Ouchi et al., 2016 | ||
| cyclin-dependent kinase 4 inhibitor D | P55273 | 55-74 | Ala-Ile-Ala-Leu-Glu-Leu-Leu-Lys-Gln-Gly-Ala-Ser-Pro-Asn+Val-Gln-Asp-Thr-Ser-Gly | P | MS | Ala | Ser | Pro | Asn | Val | Gln | Asp | Thr | Shinkai-Ouchi et al., 2016 | ||
| cyclin-dependent kinase 4 inhibitor D | P55273 | 55-74 | Ala-Ile-Ala-Leu-Glu-Leu-Leu-Lys-Gln-Gly-Ala-Ser+Pro-Asn-Val-Gln-Asp-Thr-Ser-Gly | P | MS | Gln | Gly | Ala | Ser | Pro | Asn | Val | Gln | Shinkai-Ouchi et al., 2016 | ||
| cyclin-dependent kinase 4 inhibitor D | P55273 | 55-74 | Ala-Ile-Ala-Leu-Glu-Leu-Leu-Lys-Gln-Gly-Ala+Ser-Pro-Asn-Val-Gln-Asp-Thr-Ser-Gly | P | MS | Lys | Gln | Gly | Ala | Ser | Pro | Asn | Val | Shinkai-Ouchi et al., 2016 | ||
| cyclin-dependent kinase 4 inhibitor D | P55273 | 55-74 | Ala-Ile-Ala-Leu-Glu-Leu-Leu-Lys-Gln-Gly+Ala-Ser-Pro-Asn-Val-Gln-Asp-Thr-Ser-Gly | P | MS | Leu | Lys | Gln | Gly | Ala | Ser | Pro | Asn | Shinkai-Ouchi et al., 2016 | ||
| cyclin-dependent kinase 4 inhibitor D | P55273 | 55-74 | Ala-Ile-Ala-Leu-Glu-Leu-Leu-Lys-Gln+Gly-Ala-Ser-Pro-Asn-Val-Gln-Asp-Thr-Ser-Gly | P | MS | Leu | Leu | Lys | Gln | Gly | Ala | Ser | Pro | Shinkai-Ouchi et al., 2016 | ||
| cyclin-dependent kinase 4 inhibitor D | P55273 | 55-74 | Ala-Ile-Ala-Leu-Glu-Leu-Leu-Lys+Gln-Gly-Ala-Ser-Pro-Asn-Val-Gln-Asp-Thr-Ser-Gly | P | MS | Glu | Leu | Leu | Lys | Gln | Gly | Ala | Ser | Shinkai-Ouchi et al., 2016 | ||
| cyclin-dependent kinase 4 inhibitor D | P55273 | 55-74 | Ala-Ile-Ala-Leu-Glu-Leu-Leu+Lys-Gln-Gly-Ala-Ser-Pro-Asn-Val-Gln-Asp-Thr-Ser-Gly | P | MS | Leu | Glu | Leu | Leu | Lys | Gln | Gly | Ala | Shinkai-Ouchi et al., 2016 | ||
| cyclin-dependent kinase 4 inhibitor D | P55273 | 55-74 | Ala-Ile-Ala-Leu-Glu+Leu-Leu-Lys-Gln-Gly-Ala-Ser-Pro-Asn-Val-Gln-Asp-Thr-Ser-Gly | P | MS | Ile | Ala | Leu | Glu | Leu | Leu | Lys | Gln | Shinkai-Ouchi et al., 2016 | ||
| cyclin-dependent kinase 4 inhibitor D | P55273 | 55-74 | Ala+Ile-Ala-Leu-Glu-Leu-Leu-Lys-Gln-Gly-Ala-Ser-Pro-Asn-Val-Gln-Asp-Thr-Ser-Gly | P | MS | '-' | '-' | '-' | Ala | Ile | Ala | Leu | Glu | Shinkai-Ouchi et al., 2016 | ||
| cyclin-dependent kinase 4 inhibitor D | P55273 | 56-74 | Ile-Ala-Leu-Glu-Leu-Leu-Lys-Gln-Gly+Ala-Ser-Pro-Asn-Val-Gln-Asp-Thr-Ser-Gly | P | MS | Leu | Lys | Gln | Gly | Ala | Ser | Pro | Asn | Shinkai-Ouchi et al., 2016 | ||
| cyclin-dependent kinase 5 activator 2 | Q13319 | 1-367 | peptide-Asn100+Arg-peptide | P | Gln | Gln | Arg | Asn | Arg | Glu | Asn | Leu | Patzke &Tsai, 2002 | 19171 | ||
| cyclin-dependent kinase 5 activator 2 | Q13319 | 1-367 | peptide-Leu105+Arg-peptide | P | Glu | Asn | Leu | Leu | Arg | Lys | Gly | Arg | Patzke &Tsai, 2002 | 19172 | ||
| cyclin-dependent kinase 5 activator 2 | Q13319 | 1-367 | peptide-Gly108+Arg-peptide | P | Leu | Arg | Lys | Gly | Arg | Asp | Pro | Pro | Patzke &Tsai, 2002 | 19173 | ||
| Dynorphin A (1-13) | P01213 | 207-219 | Peptide-Arg212+Arg-Peptide | N | Gly | Phe | Leu | Arg | Arg | Ile | Arg | Pro | McDermott et al., 1985 | |||
| dystrophin | P11532 | 681-700 | Val-Met-Glu-Thr-Val-Thr-Thr-Val-Thr-Thr-Arg-Glu+Gln-Ile-Leu-Val-Lys-His-Ala-Gln | P | MS | Thr | Thr | Arg | Glu | Gln | Ile | Leu | Val | Shinkai-Ouchi et al., 2016 | ||
| dystrophin | P11532 | 681-700 | Val-Met-Glu-Thr-Val-Thr-Thr-Val-Thr-Thr+Arg-Glu-Gln-Ile-Leu-Val-Lys-His-Ala-Gln | P | MS | Thr | Val | Thr | Thr | Arg | Glu | Gln | Ile | Shinkai-Ouchi et al., 2016 | ||
| EDANS-EALFAERK-Dabcyl | EDANS-Glu-Ala-Leu-Phe+Ala-Glu-Arg-Lys-Dabcyl | S | Glu | Ala | Leu | Phe | Ala | Glu | Arg | Lys | Kelly et al., 2009 | |||||
| EDANS-EPAFAERK-Dabcyl | EDANS-Glu-Pro-Ala-Phe+Ala-Glu-Arg-Lys-Dabcyl | S | Glu | Pro | Ala | Phe | Ala | Glu | Arg | Lys | Kelly et al., 2009 | |||||
| EDANS-EPLAAERK-Dabcyl | EDANS-Glu-Pro-Leu-Ala+Ala-Glu-Arg-Lys-Dabcyl | S | Glu | Pro | Leu | Ala | Ala | Glu | Arg | Lys | Kelly et al., 2009 | |||||
| EDANS-EPLFAARK-Dabcyl | EDANS-Glu-Pro-Leu-Phe+Ala-Ala-Arg-Lys-Dabcyl | S | Glu | Pro | Leu | Phe | Ala | Ala | Arg | Lys | Kelly et al., 2009 | |||||
| EDANS-EPLFAEAK-Dabcyl | EDANS-Glu-Pro-Leu-Phe+Ala-Glu-Ala-Lys-Dabcyl | S | Glu | Pro | Leu | Phe | Ala | Glu | Ala | Lys | Kelly et al., 2009 | |||||
| EDANS-EPLFAERK-Dabcyl | EDANS-Glu-Pro-Leu-Phe+Ala-Glu-Arg-Lys-Dabcyl | S | Glu | Pro | Leu | Phe | Ala | Glu | Arg | Lys | Kelly et al., 2009 | |||||
| EDANS-EPLFGERK-Dabcyl | EDANS-Glu-Pro-Leu-Phe+Gly-Glu-Arg-Lys-Dabcyl | S | Glu | Pro | Leu | Phe | Gly | Glu | Arg | Lys | Kelly et al., 2009 | |||||
| EDANS-EPLFMERK-Dabcyl | EDANS-Glu-Pro-Leu-Phe+Met-Glu-Arg-Lys-Dabcyl | S | Glu | Pro | Leu | Phe | Met | Glu | Arg | Lys | Kelly et al., 2009 | |||||
| epidermal growth factor receptor | P00533 | 674-693 | Val-Arg-Lys-Arg-Thr-Leu-Arg-Arg-Leu-Leu-Gln-Glu+Arg-Glu-Leu-Val-Glu-Pro-Leu-Thr | P | MS | Leu | Leu | Gln | Glu | Arg | Glu | Leu | Val | Shinkai-Ouchi et al., 2016 | ||
| epidermal growth factor receptor | P00533 | 674-693 | Val-Arg-Lys-Arg-Thr-Leu-Arg-Arg-Leu-Leu-Gln+Glu-Arg-Glu-Leu-Val-Glu-Pro-Leu-Thr | P | MS | Arg | Leu | Leu | Gln | Glu | Arg | Glu | Leu | Shinkai-Ouchi et al., 2016 | ||
| epidermal growth factor receptor | P00533 | 674-693 | Val-Arg-Lys-Arg-Thr-Leu-Arg-Arg-Leu-Leu+Gln-Glu-Arg-Glu-Leu-Val-Glu-Pro-Leu-Thr | P | MS | Arg | Arg | Leu | Leu | Gln | Glu | Arg | Glu | Shinkai-Ouchi et al., 2016 | ||
| epidermal growth factor receptor | P00533 | 674-693 | Val-Arg-Lys-Arg-Thr-Leu+Arg-Arg-Leu-Leu-Gln-Glu-Arg-Glu-Leu-Val-Glu-Pro-Leu-Thr | P | MS | Lys | Arg | Thr | Leu | Arg | Arg | Leu | Leu | Shinkai-Ouchi et al., 2016 | ||
| epidermal growth factor receptor precursor | P00533 | 25-1210 | peptide-Leu683+Gln-peptide | P | Arg | Arg | Leu | Leu | Gln | Glu | Arg | Glu | Gregoriou et al., 1994 | 20786 | ||
| epidermal growth factor receptor precursor | P00533 | 25-1210 | peptide-Pro733+Glu-peptide | P | Leu | Trp | Ile | Pro | Glu | Gly | Glu | Lys | Gregoriou et al., 1994 | 20787 | ||
| epidermal growth factor receptor precursor | P00533 | 25-1210 | peptide-Ser1030+Arg-peptide | P | Pro | Ser | Thr | Ser | Arg | Thr | Pro | Leu | Gregoriou et al., 1994 | 20788 | ||
| epidermal growth factor receptor precursor | P00533 | 25-1210 | peptide-Pro1059+Ile-peptide | P | Gln | Ser | Cys | Pro | Ile | Lys | Glu | Asp | Gregoriou et al., 1994 | 20789 | ||
| epidermal growth factor receptor precursor | P00533 | 25-1210 | peptide-Phe1086+Leu-peptide | P | Asp | Asp | Thr | Phe | Leu | Pro | Val | Pro | Gregoriou et al., 1994 | 20790 | ||
| epidermal growth factor receptor precursor | P00533 | 25-1210 | peptide-Phe1151+Asp-peptide | P | Asn | Ser | Thr | Phe | Asp | Ser | Pro | Ala | Gregoriou et al., 1994 | |||
| epidermal growth factor receptor precursor | P00533 | 25-1210 | peptide-Gly1185+Ile-peptide | P | Lys | Pro | Asn | Gly | Ile | Phe | Lys | Gly | Gregoriou et al., 1994 | 20791 | ||
| filamin-A | P21333 | 2-2647 | peptide-Tyr1761+Thr-peptide | N | Ala | Pro | Gln | Tyr | Thr | Tyr | Ala | Gln | 16116 | |||
| focal adhesion kinase 1 | P34152 | 2-1090 | peptide-Ser783+Gly-peptide | P | NT | Tyr | Gln | Val | Ser | Gly | Tyr | Pro | Gly | Chan et al., 2010 | ||
| Fos FBJ osteosarcoma oncogene | P12841 | 1-380 | peptide-Thr90+Arg-peptide | P | Pro | Ser | Gln | Thr | Arg | Ala | Pro | His | Pariat et al., 2000 | 26467 | ||
| glucagon | P01275 | 65-84 | Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met+Asn-Thr-Lys-Arg-Asn | P | MS | Gln | Trp | Leu | Met | Asn | Thr | Lys | Arg | Shinkai-Ouchi et al., 2016 | ||
| glucagon | P01275 | 65-84 | Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp+Leu-Met-Asn-Thr-Lys-Arg-Asn | P | MS | Phe | Val | Gln | Trp | Leu | Met | Asn | Thr | Shinkai-Ouchi et al., 2016 | ||
| glucagon | P01275 | 65-84 | Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln+Trp-Leu-Met-Asn-Thr-Lys-Arg-Asn | P | MS | Asp | Phe | Val | Gln | Trp | Leu | Met | Asn | Shinkai-Ouchi et al., 2016 | ||
| glucagon | P01275 | 70-89 | Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr-Lys+Arg-Asn-Arg-Asn-Asn-Ile-Ala | P | MS | Met | Asn | Thr | Lys | Arg | Asn | Arg | Asn | Shinkai-Ouchi et al., 2016 | ||
| glucagon | P01275 | 70-89 | Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr+Lys-Arg-Asn-Arg-Asn-Asn-Ile-Ala | P | MS | Leu | Met | Asn | Thr | Lys | Arg | Asn | Arg | Shinkai-Ouchi et al., 2016 | ||
| glucagon | P01275 | 70-89 | Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn+Thr-Lys-Arg-Asn-Arg-Asn-Asn-Ile-Ala | P | MS | Trp | Leu | Met | Asn | Thr | Lys | Arg | Asn | Shinkai-Ouchi et al., 2016 | ||
| glucagon | P01275 | 70-89 | Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met+Asn-Thr-Lys-Arg-Asn-Arg-Asn-Asn-Ile-Ala | P | MS | Gln | Trp | Leu | Met | Asn | Thr | Lys | Arg | Shinkai-Ouchi et al., 2016 | ||
| glucagon | P01275 | 70-89 | Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp+Leu-Met-Asn-Thr-Lys-Arg-Asn-Arg-Asn-Asn-Ile-Ala | P | MS | Phe | Val | Gln | Trp | Leu | Met | Asn | Thr | Shinkai-Ouchi et al., 2016 | ||
| glutamate receptor ionotropic, NMDA 2A | Q00959 | 1269-1288 | Gln-Asp-Trp-Ser-Gln-Asn-Asn-Ala-Leu-Gln-Phe-Gln-Lys-Asn-Lys-Leu-Arg+Ile-Asn-Arg | P | MS | Asn | Lys | Leu | Arg | Ile | Asn | Arg | '-' | Shinkai-Ouchi et al., 2016 | ||
| glutamate receptor ionotropic, NMDA 2A | Q00959 | 1269-1288 | Gln-Asp-Trp-Ser-Gln-Asn-Asn-Ala-Leu-Gln-Phe+Gln-Lys-Asn-Lys-Leu-Arg-Ile-Asn-Arg | P | MS | Ala | Leu | Gln | Phe | Gln | Lys | Asn | Lys | Shinkai-Ouchi et al., 2016 | ||
| glutamate receptor ionotropic, NMDA 2A | Q00959 | 1269-1288 | Gln-Asp-Trp-Ser-Gln-Asn-Asn-Ala-Leu-Gln+Phe-Gln-Lys-Asn-Lys-Leu-Arg-Ile-Asn-Arg | P | MS | Asn | Ala | Leu | Gln | Phe | Gln | Lys | Asn | Shinkai-Ouchi et al., 2016 | ||
| glutamate receptor ionotropic, NMDA 2A | Q00959 | 1269-1288 | Gln-Asp-Trp-Ser-Gln-Asn-Asn-Ala-Leu+Gln-Phe-Gln-Lys-Asn-Lys-Leu-Arg-Ile-Asn-Arg | P | MS | Asn | Asn | Ala | Leu | Gln | Phe | Gln | Lys | Shinkai-Ouchi et al., 2016 | ||
| glycine transporter variant 1a, Isoform 2 | P28572-1 | 1-633 | peptide-Thr26+Arg-peptide | P | Gln | Asn | Leu | Thr | Arg | Gly | Asn | Trp | Baliova & Jursky, 2005 | 20878 | ||
| glycine transporter variant 1b | P28572 | 1-638 | peptide-Gly17+Ala-peptide | P | Glu | Gln | Asn | Gly | Ala | Val | Pro | Ser | Baliova & Jursky, 2005 | 20879 | ||
| glycine transporter variant 1b | P28572 | 1-638 | peptide-Thr31+Arg-peptide | P | Gln | Asn | Leu | Thr | Arg | Gly | Asn | Trp | Baliova & Jursky, 2005 | 20880 | ||
| Gonadoliberin-1 | P01148 | 24-33 | Peptide-Gly29+Leu-Peptide | N | Trp | Ser | Tyr | Gly | Leu | Arg | Pro | Gly | McDermott et al., 1985 | |||
| hemoglobin subunit alpha | P69905 | 10-21 | Asn-Val-Lys-Ala-Ala-Trp-Gly-Lys-Val-Gly+Ala-His | P | MS | Gly | Lys | Val | Gly | Ala | His | '-' | '-' | Shinkai-Ouchi et al., 2016 | ||
| hemoglobin subunit alpha | P69905 | 2-21 | Val-Leu-Ser-Pro-Ala-Asp-Lys-Thr-Asn-Val-Lys+Ala-Ala-Trp-Gly-Lys-Val-Gly-Ala-His | P | MS | Thr | Asn | Val | Lys | Ala | Ala | Trp | Gly | Shinkai-Ouchi et al., 2016 | ||
| hemoglobin subunit alpha | P69905 | 2-21 | Val-Leu-Ser-Pro-Ala-Asp-Lys-Thr-Asn-Val+Lys-Ala-Ala-Trp-Gly-Lys-Val-Gly-Ala-His | P | MS | Lys | Thr | Asn | Val | Lys | Ala | Ala | Trp | Shinkai-Ouchi et al., 2016 | ||
| hemoglobin subunit alpha | P69905 | 2-21 | Val+Leu-Ser-Pro-Ala-Asp-Lys-Thr-Asn-Val-Lys-Ala-Ala-Trp-Gly-Lys-Val-Gly-Ala-His | P | MS | '-' | '-' | '-' | Val | Leu | Ser | Pro | Ala | Shinkai-Ouchi et al., 2016 | ||
| hemoglobin subunit beta | P68871 | 1-19 | Met-Val-His-Leu-Thr-Pro-Glu-Glu-Lys-Ser-Ala-Val-Thr-Ala-Leu-Trp+Gly-Lys-Val | P | MS | Thr | Ala | Leu | Trp | Gly | Lys | Val | '-' | Shinkai-Ouchi et al., 2016 | ||
| hemoglobin subunit beta | P68871 | 1-19 | Met-Val-His-Leu-Thr-Pro-Glu-Glu-Lys-Ser-Ala-Val-Thr+Ala-Leu-Trp-Gly-Lys-Val | P | MS | Ser | Ala | Val | Thr | Ala | Leu | Trp | Gly | Shinkai-Ouchi et al., 2016 | ||
| hemoglobin subunit beta | P68871 | 1-19 | Met-Val-His-Leu-Thr-Pro-Glu-Glu-Lys+Ser-Ala-Val-Thr-Ala-Leu-Trp-Gly-Lys-Val | P | MS | Pro | Glu | Glu | Lys | Ser | Ala | Val | Thr | Shinkai-Ouchi et al., 2016 | ||
| hemoglobin subunit beta | P68871 | 6-19 | Pro-Glu-Glu-Lys-Ser-Ala-Val-Thr-Ala-Leu-Trp+Gly-Lys-Val | P | MS | Thr | Ala | Leu | Trp | Gly | Lys | Val | '-' | Shinkai-Ouchi et al., 2016 | ||
| huntingtin | P42858 | 1-3142 | peptide-Thr469+Ala-peptide | P | Ser | Ala | Leu | Thr | Ala | Ser | Val | Lys | Gafni et al., 2004 | 20340 | ||
| huntingtin | P42858 | 1-3142 | peptide-Ser536+Ser-peptide | P | Ser | His | Ser | Ser | Ser | Gln | Val | Ser | Gafni et al., 2004 | 20339 | ||
| insulin-like growth factor-binding protein 4 | P22692 | 147-166 | Arg-Asp-Arg-Ser-Thr-Ser-Gly-Gly-Lys-Met-Lys-Val-Asn-Gly+Ala-Pro-Arg-Glu-Asp-Ala | P | MS | Lys | Val | Asn | Gly | Ala | Pro | Arg | Glu | Shinkai-Ouchi et al., 2016 | ||
| insulin-like growth factor-binding protein 4 | P22692 | 147-166 | Arg-Asp-Arg-Ser-Thr-Ser-Gly-Gly-Lys-Met-Lys-Val-Asn+Gly-Ala-Pro-Arg-Glu-Asp-Ala | P | MS | Met | Lys | Val | Asn | Gly | Ala | Pro | Arg | Shinkai-Ouchi et al., 2016 | ||
| insulin-like growth factor-binding protein 4 | P22692 | 147-166 | Arg-Asp-Arg-Ser-Thr-Ser-Gly-Gly-Lys-Met+Lys-Val-Asn-Gly-Ala-Pro-Arg-Glu-Asp-Ala | P | MS | Gly | Gly | Lys | Met | Lys | Val | Asn | Gly | Shinkai-Ouchi et al., 2016 | ||
| insulin-like growth factor-binding protein 4 | P22692 | 147-166 | Arg-Asp+Arg-Ser-Thr-Ser-Gly-Gly-Lys-Met-Lys-Val-Asn-Gly-Ala-Pro-Arg-Glu-Asp-Ala | P | MS | '-' | '-' | Arg | Asp | Arg | Ser | Thr | Ser | Shinkai-Ouchi et al., 2016 | ||
| insulin-like growth factor-binding protein 5 | P24593 | 149-168 | Ala-Glu-Ala-Val-Lys-Lys-Asp-Arg-Arg-Lys-Lys-Leu-Thr-Gln+Ser-Lys-Phe-Val-Gly-Gly | P | MS | Lys | Leu | Thr | Gln | Ser | Lys | Phe | Val | Shinkai-Ouchi et al., 2016 | ||
| insulin-like growth factor-binding protein 5 | P24593 | 149-168 | Ala-Glu-Ala-Val-Lys-Lys-Asp-Arg-Arg-Lys-Lys-Leu-Thr+Gln-Ser-Lys-Phe-Val-Gly-Gly | P | MS | Lys | Lys | Leu | Thr | Gln | Ser | Lys | Phe | Shinkai-Ouchi et al., 2016 | ||
| insulin-like growth factor-binding protein 5 | P24593 | 149-168 | Ala-Glu-Ala-Val-Lys-Lys-Asp-Arg-Arg-Lys+Lys-Leu-Thr-Gln-Ser-Lys-Phe-Val-Gly-Gly | P | MS | Asp | Arg | Arg | Lys | Lys | Leu | Thr | Gln | Shinkai-Ouchi et al., 2016 | ||
| integrin beta-1 | P05556 | 762-781 | Glu-Phe-Ala-Lys-Phe-Glu-Lys-Glu-Lys-Met+Asn-Ala-Lys-Trp-Asp-Thr-Gly-Glu-Asn-Pro | P | MS | Lys | Glu | Lys | Met | Asn | Ala | Lys | Trp | Shinkai-Ouchi et al., 2016 | ||
| integrin beta-2 | P05107 | 745-764 | Ser-Gln-Trp-Asn-Asn-Asp-Asn-Pro-Leu-Phe-Lys-Ser-Ala-Thr-Thr-Thr-Val-Met+Asn-Pro | P | MS | Thr | Thr | Val | Met | Asn | Pro | '-' | '-' | Shinkai-Ouchi et al., 2016 | ||
| integrin beta-2 | P05107 | 745-764 | Ser-Gln-Trp-Asn-Asn-Asp-Asn-Pro-Leu-Phe-Lys-Ser+Ala-Thr-Thr-Thr-Val-Met-Asn-Pro | P | MS | Leu | Phe | Lys | Ser | Ala | Thr | Thr | Thr | Shinkai-Ouchi et al., 2016 | ||
| integrin beta-2 | P05107 | 745-764 | Ser-Gln-Trp-Asn-Asn-Asp-Asn-Pro-Leu-Phe-Lys+Ser-Ala-Thr-Thr-Thr-Val-Met-Asn-Pro | P | MS | Pro | Leu | Phe | Lys | Ser | Ala | Thr | Thr | Shinkai-Ouchi et al., 2016 | ||
| integrin beta-2 | P05107 | 745-764 | Ser-Gln-Trp-Asn-Asn-Asp-Asn-Pro-Leu-Phe+Lys-Ser-Ala-Thr-Thr-Thr-Val-Met-Asn-Pro | P | MS | Asn | Pro | Leu | Phe | Lys | Ser | Ala | Thr | Shinkai-Ouchi et al., 2016 | ||
| integrin beta-2 precursor | P05107 | 23-769 | peptide-Met762+Asn-peptide | P | Thr | Thr | Val | Met | Asn | Pro | Lys | Phe | Pfaff et al., 1999 | 18730 | ||
| integrin beta-2 precursor | P05107 | 23-769 | peptide-Lys744+Ser-peptide | P | Glu | Lys | Leu | Lys | Ser | Gln | Trp | Asn | Pfaff et al., 1999 | 18728 | ||
| integrin beta-2 precursor | P05107 | 23-769 | peptide-Phe754+Lys-peptide | P | Asn | Pro | Leu | Phe | Lys | Ser | Ala | Thr | Pfaff et al., 1999 | 18729 | ||
| integrin beta-3 | P05106 | 771-783 | Pro-Leu-Tyr-Lys-Glu+Ala-Thr-Ser-Thr-Phe-Thr-Asn-Ile | P | MS | Leu | Tyr | Lys | Glu | Ala | Thr | Ser | Thr | Shinkai-Ouchi et al., 2016 | ||
| integrin beta-3 | P05106 | 771-783 | Pro-Leu-Tyr-Lys+Glu-Ala-Thr-Ser-Thr-Phe-Thr-Asn-Ile | P | MS | Pro | Leu | Tyr | Lys | Glu | Ala | Thr | Ser | Shinkai-Ouchi et al., 2016 | ||
| integrin beta-3 | P05106 | 771-783 | Pro-Leu-Tyr+Lys-Glu-Ala-Thr-Ser-Thr-Phe-Thr-Asn-Ile | P | MS | '-' | Pro | Leu | Tyr | Lys | Glu | Ala | Thr | Shinkai-Ouchi et al., 2016 | ||
| integrin beta-7 | P26010 | 769-788 | Asn-Trp-Lys-Gln-Asp-Ser-Asn-Pro-Leu-Tyr-Lys-Ser+Ala-Ile-Thr-Thr-Thr-Ile-Asn-Pro | P | MS | Leu | Tyr | Lys | Ser | Ala | Ile | Thr | Thr | Shinkai-Ouchi et al., 2016 | ||
| integrin beta-7 | P26010 | 769-788 | Asn-Trp-Lys-Gln-Asp-Ser-Asn-Pro-Leu-Tyr-Lys+Ser-Ala-Ile-Thr-Thr-Thr-Ile-Asn-Pro | P | MS | Pro | Leu | Tyr | Lys | Ser | Ala | Ile | Thr | Shinkai-Ouchi et al., 2016 | ||
| integrin beta-7 | P26010 | 769-788 | Asn-Trp-Lys-Gln-Asp-Ser-Asn-Pro-Leu-Tyr+Lys-Ser-Ala-Ile-Thr-Thr-Thr-Ile-Asn-Pro | P | MS | Asn | Pro | Leu | Tyr | Lys | Ser | Ala | Ile | Shinkai-Ouchi et al., 2016 | ||
| integrin beta-7 | P26010 | 769-788 | Asn-Trp-Lys-Gln-Asp-Ser-Asn-Pro+Leu-Tyr-Lys-Ser-Ala-Ile-Thr-Thr-Thr-Ile-Asn-Pro | P | MS | Asp | Ser | Asn | Pro | Leu | Tyr | Lys | Ser | Shinkai-Ouchi et al., 2016 | ||
| interleukin-1 alpha | P01583 | 109-128 | Ile-Lys-Pro-Arg-Ser-Ala-Pro-Phe-Ser-Phe-Leu-Ser-Asn+Val-Lys-Tyr-Asn-Phe-Met-Arg | P | MS | Phe | Leu | Ser | Asn | Val | Lys | Tyr | Asn | Shinkai-Ouchi et al., 2016 | ||
| interleukin-1 alpha | P01583 | 109-128 | Ile-Lys-Pro-Arg-Ser-Ala-Pro-Phe-Ser-Phe-Leu-Ser+Asn-Val-Lys-Tyr-Asn-Phe-Met-Arg | P | MS | Ser | Phe | Leu | Ser | Asn | Val | Lys | Tyr | Shinkai-Ouchi et al., 2016 | ||
| interleukin-1 alpha | P01583 | 109-128 | Ile-Lys-Pro-Arg-Ser-Ala-Pro-Phe-Ser-Phe+Leu-Ser-Asn-Val-Lys-Tyr-Asn-Phe-Met-Arg | P | MS | Pro | Phe | Ser | Phe | Leu | Ser | Asn | Val | Shinkai-Ouchi et al., 2016 | ||
| interleukin-1 alpha | P01583 | 109-128 | Ile-Lys+Pro-Arg-Ser-Ala-Pro-Phe-Ser-Phe-Leu-Ser-Asn-Val-Lys-Tyr-Asn-Phe-Met-Arg | P | MS | '-' | '-' | Ile | Lys | Pro | Arg | Ser | Ala | Shinkai-Ouchi et al., 2016 | ||
| jun protein | Q52L79 | 155-174 | Gly-Gly-Gly-Gly-Tyr-Ser-Ala-Ser-Leu-His-Ser-Glu-Pro-Pro-Val-Tyr+Ala-Asn-Leu-Ser | P | MS | Pro | Pro | Val | Tyr | Ala | Asn | Leu | Ser | Shinkai-Ouchi et al., 2016 | ||
| jun protein | Q52L79 | 155-174 | Gly-Gly-Gly-Gly-Tyr-Ser-Ala-Ser-Leu-His+Ser-Glu-Pro-Pro-Val-Tyr-Ala-Asn-Leu-Ser | P | MS | Ala | Ser | Leu | His | Ser | Glu | Pro | Pro | Shinkai-Ouchi et al., 2016 | ||
| jun protein | Q52L79 | 155-174 | Gly-Gly+Gly-Gly-Tyr-Ser-Ala-Ser-Leu-His-Ser-Glu-Pro-Pro-Val-Tyr-Ala-Asn-Leu-Ser | P | MS | '-' | '-' | Gly | Gly | Gly | Gly | Tyr | Ser | Shinkai-Ouchi et al., 2016 | ||
| jun protein | Q52L79 | 156-174 | Gly-Gly-Gly-Tyr-Ser-Ala-Ser-Leu-His+Ser-Glu-Pro-Pro-Val-Tyr-Ala-Asn-Leu-Ser | P | MS | Ala | Ser | Leu | His | Ser | Glu | Pro | Pro | Shinkai-Ouchi et al., 2016 | ||
| Jun v-jun sarcoma virus 17 oncogene homolog | P17325 | 1-334 | peptide-Leu42+Ala-peptide | P | Thr | Leu | Asn | Leu | Ala | Asp | Pro | Val | Pariat et al., 2000 | 26468 | ||
| Jun v-jun sarcoma virus 17 oncogene homolog | P17325 | 1-334 | peptide-Thr62+Ser-peptide | P | Asp | Leu | Leu | Thr | Ser | Pro | Asp | Val | Pariat et al., 2000 | 26469 | ||
| Jun v-jun sarcoma virus 17 oncogene homolog | P17325 | 1-334 | peptide-Thr90+Thr-peptide | P | His | Ile | Thr | Thr | Thr | Pro | Thr | Pro | Pariat et al., 2000 | 26470 | ||
| Jun v-jun sarcoma virus 17 oncogene homolog | P17325 | 1-334 | peptide-His164+Ser-peptide | P | Ala | Ser | Leu | His | Ser | Glu | Pro | Pro | Pariat et al., 2000 | 26471 | ||
| junctophilin-2 | Q9ET78 | 1-696 | peptide-Arg565+Thr-peptide | P | NT | Tyr | Ala | Val | Arg | Thr | Gly | Pro | Pro | Wang et al., 2021 | ||
| kininogen-1 | P01042 | 19-644 | peptide-Arg371+Ser-peptide | P | Ser | Pro | Phe | Arg | Ser | Ser | Arg | Ile | Imamura et al., 2004 | |||
| kininogen-1 | P01042 | 19-644 | peptide-Met361+Lys-peptide | P | Ile | Ser | Leu | Met | Lys | Arg | Pro | Pro | Imamura et al., 2004 | |||
| lens fiber major intrinsic protein | P30301 | 1-263 | peptide-Lys238+Gly-peptide | P | Ser | Val | Leu | Lys | Gly | Ala | Lys | Pro | Ma et al., 2005 | 19688 | ||
| lens fiber major intrinsic protein | P30301 | 1-263 | peptide-Thr252+Gly-peptide | P | Pro | Glu | Val | Thr | Gly | Glu | Pro | Val | Ma et al., 2005 | 19689 | ||
| lens fiber major intrinsic protein | P30301 | 1-263 | peptide-Asn259+Thr-peptide | P | Val | Glu | Leu | Asn | Thr | Gln | Ala | Leu | Ma et al., 2005 | 19690 | ||
| lens fiber major intrinsic protein | P30301 | 1-263 | peptide-Thr260+Gln-peptide | P | Glu | Leu | Asn | Thr | Gln | Ala | Leu | Gly | Ma et al., 2005 | 19691 | ||
| lens fiber major intrinsic protein | P30301 | 230-248 | Ile-Ser-Glu-Arg-Leu-Ser-Val-Leu-Lys+Gly-Ala-Lys-Pro-Asp-Val-Ser-Asn-Gly-Gln | P | MS | Ser | Val | Leu | Lys | Gly | Ala | Lys | Pro | Shinkai-Ouchi et al., 2016 | ||
| lens fiber major intrinsic protein | P30301 | 231-248 | Ser-Glu-Arg-Leu-Ser-Val-Leu-Lys+Gly-Ala-Lys-Pro-Asp-Val-Ser-Asn-Gly-Gln | P | MS | Ser | Val | Leu | Lys | Gly | Ala | Lys | Pro | Shinkai-Ouchi et al., 2016 | ||
| lens fiber major intrinsic protein | P30301 | 229-248 | Ser-Ile-Ser-Glu-Arg-Leu-Ser-Val-Leu-Lys+Gly-Ala-Lys-Pro-Asp-Val-Ser-Asn-Gly-Gln | P | MS | Ser | Val | Leu | Lys | Gly | Ala | Lys | Pro | Shinkai-Ouchi et al., 2016 | ||
| lens fiber major intrinsic protein | P30301 | 229-248 | Ser-Ile-Ser-Glu-Arg-Leu-Ser+Val-Leu-Lys-Gly-Ala-Lys-Pro-Asp-Val-Ser-Asn-Gly-Gln | P | MS | Glu | Arg | Leu | Ser | Val | Leu | Lys | Gly | Shinkai-Ouchi et al., 2016 | ||
| lens fiber major intrinsic protein | P30301 | 229-248 | Ser-Ile+Ser-Glu-Arg-Leu-Ser-Val-Leu-Lys-Gly-Ala-Lys-Pro-Asp-Val-Ser-Asn-Gly-Gln | P | MS | '-' | '-' | Ser | Ile | Ser | Glu | Arg | Leu | Shinkai-Ouchi et al., 2016 | ||
| lens fiber major intrinsic protein | P30301 | 229-248 | Ser+Ile-Ser-Glu-Arg-Leu-Ser-Val-Leu-Lys-Gly-Ala-Lys-Pro-Asp-Val-Ser-Asn-Gly-Gln | P | MS | '-' | '-' | '-' | Ser | Ile | Ser | Glu | Arg | Shinkai-Ouchi et al., 2016 | ||
| merlin | P35240 | 1-595 | peptide-Lys294+Leu-peptide | P | Arg | Val | Asn | Lys | Leu | Ile | Leu | Gln | Kimura et al., 1998 | 20859 | ||
| merlin | P35240 | 1-595 | peptide-Gln298+Leu-peptide | P | Leu | Ile | Leu | Gln | Leu | Cys | Ile | Gly | Kimura et al., 1998 | 20860 | ||
| microtubule-associated protein tau | P10636 | 2-758 | peptide-Met11+Glu-peptide | P | Phe | Glu | Val | Met | Glu | Asp | His | Ala | Yang et al., 1995 | 26367 | ||
| microtubule-associated protein tau | P10636 | 2-758 | peptide-Lys44+Glu-peptide | P | Ala | Gly | Leu | Lys | Glu | Ser | Pro | Leu | Yang et al., 1995 | 26343 | ||
| microtubule-associated protein tau | P10636 | 2-758 | peptide-Arg547+Thr-peptide | P | Ala | Val | Val | Arg | Thr | Pro | Pro | Lys | Yang et al., 1995 | 26368 | ||
| microtubule-associated protein tau | P10636 | 2-758 | peptide-Lys571+Asn-peptide | P | Pro | Asp | Leu | Lys | Asn | Val | Lys | Ser | Yang et al., 1995 | 26369 | ||
| microtubule-associated protein tau | P10636 | 2-758 | peptide-Lys574+Ser-peptide | P | Lys | Asn | Val | Lys | Ser | Lys | Ile | Gly | Yang et al., 1995 | 26370 | ||
| microtubule-associated protein tau | P10636 | 2-758 | peptide-Lys584+His-peptide | P | Glu | Asn | Leu | Lys | His | Gln | Pro | Gly | Yang et al., 1995 | 26371 | ||
| microtubule-associated protein tau | P10636 | 2-758 | peptide-Tyr627+Lys-peptide | P | Gln | Ile | Val | Tyr | Lys | Pro | Val | Asp | Yang et al., 1995 | 26372 | ||
| microtubule-associated protein tau | P10636 | 2-758 | peptide-Lys657+Ser-peptide | P | Val | Glu | Val | Lys | Ser | Glu | Lys | Leu | Yang et al., 1995 | 26373 | ||
| microtubule-associated protein tau | P10636 | 2-758 | peptide-Tyr711+Lys-peptide | P | Glu | Ile | Val | Tyr | Lys | Ser | Pro | Val | Yang et al., 1995 | 26374 | ||
| Microtubule-associated protein tau, isoform Tau-E | P19332-5 | 1-432 | Peptide-Ser120+Lys-Peptide | N | NT | Ala | Gly | Val | Ser | Lys | Asp | Arg | Thr | Liu et al., 2011 | ||
| Microtubule-associated protein tau, isoform Tau-E | P19332-5 | 1-432 | Peptide-Pro209+Pro-Peptide | N | NT | Leu | Pro | Thr | Pro | Pro | Thr | Arg | Glu | Liu et al., 2011 | ||
| Microtubule-associated protein tau, isoform Tau-E | P19332-5 | 1-432 | Peptide-Arg370+Glu-Peptide | N | NT | Leu | Thr | Phe | Arg | Glu | Asn | Ala | Lys | Liu et al., 2011 | ||
| myelin basic protein | P02687 | 1-169 | peptide-Val93+Thr-peptide | P | Lys | Asn | Ile | Val | Thr | Pro | Arg | Thr | Tsubata & Takahashi, 1989 | |||
| myelin basic protein | P02687 | 1-169 | peptide-Ala16+Ser-peptide | P | Leu | Ala | Ser | Ala | Ser | Thr | Met | Asp | Tsubata & Takahashi, 1989 | |||
| myelin basic protein | P02687 | 1-169 | peptide-Gly68+Ser-peptide | P | Thr | His | Tyr | Gly | Ser | Leu | Pro | Gln | Tsubata & Takahashi, 1989 | |||
| myelin basic protein | P02687 | 1-169 | peptide-Arg96+Thr-peptide | P | Val | Thr | Pro | Arg | Thr | Pro | Pro | Pro | Tsubata & Takahashi, 1989 | 26463 | ||
| myelin basic protein | P02686 | 219-238 | Pro-Val-Val-His-Phe-Phe-Lys-Asn-Ile-Val-Thr-Pro-Arg-Thr-Pro-Pro-Pro-Ser-Gln+Gly | P | MS | Pro | Pro | Ser | Gln | Gly | '-' | '-' | '-' | Shinkai-Ouchi et al., 2016 | ||
| myelin basic protein | P02686 | 219-238 | Pro-Val-Val-His-Phe-Phe-Lys-Asn-Ile-Val-Thr-Pro-Arg+Thr-Pro-Pro-Pro-Ser-Gln-Gly | P | MS | Val | Thr | Pro | Arg | Thr | Pro | Pro | Pro | Shinkai-Ouchi et al., 2016 | ||
| myelin basic protein | P02686 | 219-238 | Pro-Val-Val-His-Phe-Phe-Lys-Asn-Ile-Val-Thr-Pro+Arg-Thr-Pro-Pro-Pro-Ser-Gln-Gly | P | MS | Ile | Val | Thr | Pro | Arg | Thr | Pro | Pro | Shinkai-Ouchi et al., 2016 | ||
| myelin basic protein | P02686 | 219-238 | Pro-Val-Val-His-Phe-Phe-Lys-Asn-Ile-Val+Thr-Pro-Arg-Thr-Pro-Pro-Pro-Ser-Gln-Gly | P | MS | Lys | Asn | Ile | Val | Thr | Pro | Arg | Thr | Shinkai-Ouchi et al., 2016 | ||
| myelin basic protein | P02686 | 219-238 | Pro-Val-Val-His+Phe-Phe-Lys-Asn-Ile-Val-Thr-Pro-Arg-Thr-Pro-Pro-Pro-Ser-Gln-Gly | P | MS | Pro | Val | Val | His | Phe | Phe | Lys | Asn | Shinkai-Ouchi et al., 2016 | ||
| myelin basic protein | F6QBP1 | 14-27 | Leu-Ala-Ser-Ala-Ser-Thr-Met-Asp-His-Ala+Arg-His-Gly-Phe | P | MS | Met | Asp | His | Ala | Arg | His | Gly | Phe | Shinkai-Ouchi et al., 2016 | ||
| myelin basic protein | F6QBP1 | 8-27 | Ser-Gln-Arg-Ser-Lys-Tyr-Leu-Ala-Ser-Ala-Ser-Thr-Met+Asp-His-Ala-Arg-His-Gly-Phe | P | MS | Ala | Ser | Thr | Met | Asp | His | Ala | Arg | Shinkai-Ouchi et al., 2016 | ||
| myelin basic protein | F6QBP1 | 8-27 | Ser-Gln-Arg-Ser-Lys-Tyr-Leu-Ala-Ser-Ala-Ser-Thr+Met-Asp-His-Ala-Arg-His-Gly-Phe | P | MS | Ser | Ala | Ser | Thr | Met | Asp | His | Ala | Shinkai-Ouchi et al., 2016 | ||
| myelin basic protein | F6QBP1 | 8-27 | Ser-Gln-Arg-Ser-Lys-Tyr-Leu-Ala-Ser-Ala-Ser+Thr-Met-Asp-His-Ala-Arg-His-Gly-Phe | P | MS | Ala | Ser | Ala | Ser | Thr | Met | Asp | His | Shinkai-Ouchi et al., 2016 | ||
| myelin basic protein | F6QBP1 | 8-27 | Ser-Gln-Arg-Ser-Lys-Tyr-Leu-Ala-Ser+Ala-Ser-Thr-Met-Asp-His-Ala-Arg-His-Gly-Phe | P | MS | Tyr | Leu | Ala | Ser | Ala | Ser | Thr | Met | Shinkai-Ouchi et al., 2016 | ||
| myelin basic protein | F6QBP1 | 8-27 | Ser-Gln-Arg-Ser-Lys-Tyr-Leu-Ala+Ser-Ala-Ser-Thr-Met-Asp-His-Ala-Arg-His-Gly-Phe | P | MS | Lys | Tyr | Leu | Ala | Ser | Ala | Ser | Thr | Shinkai-Ouchi et al., 2016 | ||
| myelin basic protein | F6QBP1 | 8-27 | Ser-Gln-Arg-Ser-Lys-Tyr-Leu+Ala-Ser-Ala-Ser-Thr-Met-Asp-His-Ala-Arg-His-Gly-Phe | P | MS | Ser | Lys | Tyr | Leu | Ala | Ser | Ala | Ser | Shinkai-Ouchi et al., 2016 | ||
| myelin basic protein | F6QBP1 | 8-27 | Ser-Gln-Arg-Ser-Lys+Tyr-Leu-Ala-Ser-Ala-Ser-Thr-Met-Asp-His-Ala-Arg-His-Gly-Phe | P | MS | Gln | Arg | Ser | Lys | Tyr | Leu | Ala | Ser | Shinkai-Ouchi et al., 2016 | ||
| myelin basic protein | F6QBP1 | 8-27 | Ser-Gln-Arg-Ser-Lys-Tyr-Leu-Ala-Ser-Ala-Ser-Thr-Met-Asp-His-Ala-Arg-His-Gly-Phe | P | MS | '-' | '-' | '-' | '-' | Ser | Gln | Arg | Ser | Shinkai-Ouchi et al., 2016 | ||
| myelin basic protein isoform 1 | P02686 | 135-304 | peptide-Ala19+Ser-peptide | P | AA | Leu | Ala | Thr | Ala | Ser | Thr | Met | Asp | Banik et al., 1994 | 26419 | |
| myelin basic protein isoform 1 | P02686 | 135-304 | peptide-His24+Ala-peptide | P | AA | Thr | Met | Asp | His | Ala | Arg | His | Gly | Banik et al., 1994 | 26420 | |
| myelin basic protein isoform 1 | P02686 | 135-304 | peptide-Gly28+Phe-peptide | P | AA | Ala | Arg | His | Gly | Phe | Leu | Pro | Arg | Banik et al., 1994 | 26421 | |
| myelin basic protein isoform 1 | P02686 | 135-304 | peptide-Arg50+Gly-peptide | P | AA | Gly | Gly | Asp | Arg | Gly | Ala | Pro | Lys | Banik et al., 1994 | 26422 | |
| myelin basic protein isoform 1 | P02686 | 135-304 | peptide-Gly204+Ser-peptide | P | AA | Ala | His | Tyr | Gly | Ser | Leu | Pro | Gln | Banik et al., 1994 | 26448 | |
| myelin basic protein isoform 1 | P02686 | 135-304 | peptide-Ser137+Leu-peptide | P | AA | Arg | Gly | Leu | Ser | Leu | Ser | Arg | Phe | Banik et al., 1994 | 26450 | |
| myelin basic protein isoform 1 | P02686 | 135-304 | peptide-Asp172+Ala-peptide | P | AA | Lys | Gly | Val | Asp | Ala | Gln | Gly | Thr | Banik et al., 1994 | 26451 | |
| myelin basic protein isoform 1 | P02686 | 135-304 | peptide-Leu183+Gly-peptide | P | AA | Ile | Phe | Lys | Leu | Gly | Gly | Arg | Asp | Banik et al., 1994 | 26452 | |
| myelin basic protein isoform 1 | P02686 | 135-304 | peptide-Ala158+Ser-peptide | P | Gly | Gly | Arg | Ala | Ser | Asp | Tyr | Lys | Medveczky et al., 2006 | 26607 | ||
| myelin basic protein isoform 1 | P02686 | 135-304 | peptide-Asp193+Ser-peptide | P | NT | Ser | Gly | Lys | Asp | Ser | His | His | Pro | Banik et al., 1994 | ||
| myelin basic protein isoform 1 | P02686 | 135-304 | peptide-Val228+Thr-peptide | P | NT | Lys | Asn | Ile | Val | Thr | Pro | Arg | Thr | Banik et al., 1994 | ||
| myelin basic protein isoform 1 | P02686 | 135-304 | peptide-Arg231+Thr-peptide | P | NT | Val | Thr | Pro | Arg | Thr | Pro | Pro | Pro | Banik et al., 1994 | 26454 | |
| myocilin | Q99972 | 1-504 | peptide-Arg226+Ile-peptide | P | NT | Pro | Ala | Ser | Arg | Ile | Leu | Lys | Glu | Sanchez-Sanchez %eal, 2006 | ||
| myosin-Va | Q02440 | 1-1829 | peptide-Arg1140+Met-peptide | P | NT | Leu | Pro | Leu | Arg | Met | Glu | Glu | Pro | Alexandra et al., 1996 | ||
| neurofilament medium polypeptide | O77788 | 507-532 | peptide-Lys523+Glu-peptide | P | MS | Pro | Glu | Leu | Lys | Glu | Glu | Glu | Gly | Shinkai-Ouchi et al., 2016 | ||
| neurofilament medium polypeptide | O77788 | 507-532 | peptide-Ala517+Thr-peptide | P | MS | Pro | Val | Lys | Ala | Thr | Ala | Pro | Glu | Shinkai-Ouchi et al., 2016 | ||
| neurofilament medium polypeptide | O77788 | 507-532 | peptide-Lys516+Ala-peptide | P | MS | Ser | Pro | Val | Lys | Ala | Thr | Ala | Pro | Shinkai-Ouchi et al., 2016 | ||
| neurofilament medium polypeptide | O77788 | 507-532 | Val-Val+Ala-peptide | P | MS | '-' | Val | Val | Ala | Ala | Lys | Lys | Ser | Shinkai-Ouchi et al., 2016 | ||
| neuromodulin | P17677 | 34-50 | Ala-Ala-Thr-Lys-Ile-Gln-Ala-Ser-Phe-Arg-Gly-His-Ile-Thr+Arg-Lys-Lys | P | MS | Gly | His | Ile | Thr | Arg | Lys | Lys | '-' | Shinkai-Ouchi et al., 2016 | ||
| neuromodulin | P17677 | 31-50 | Ala-His-Lys-Ala-Ala-Thr-Lys-Ile-Gln-Ala-Ser-Phe-Arg-Gly-His-Ile-Thr+Arg-Lys-Lys | P | MS | Gly | His | Ile | Thr | Arg | Lys | Lys | '-' | Shinkai-Ouchi et al., 2016 | ||
| neuromodulin | P17677 | 31-50 | Ala-His-Lys-Ala-Ala-Thr-Lys-Ile-Gln-Ala-Ser-Phe+Arg-Gly-His-Ile-Thr-Arg-Lys-Lys | P | MS | Gln | Ala | Ser | Phe | Arg | Gly | His | Ile | Shinkai-Ouchi et al., 2016 | ||
| neuromodulin | P17677 | 31-50 | Ala-His-Lys-Ala-Ala-Thr-Lys-Ile-Gln-Ala+Ser-Phe-Arg-Gly-His-Ile-Thr-Arg-Lys-Lys | P | MS | Lys | Ile | Gln | Ala | Ser | Phe | Arg | Gly | Shinkai-Ouchi et al., 2016 | ||
| neuromodulin | P17677 | 31-50 | Ala-His-Lys-Ala-Ala-Thr-Lys-Ile-Gln+Ala-Ser-Phe-Arg-Gly-His-Ile-Thr-Arg-Lys-Lys | P | MS | Thr | Lys | Ile | Gln | Ala | Ser | Phe | Arg | Shinkai-Ouchi et al., 2016 | ||
| Neurotensin | P30990 | 151-163 | Gln-Leu-Tyr153+Glu-Peptide | N | - | Gln | Leu | Tyr | Glu | Asn | Lys | Pro | McDermott et al., 1985 | |||
| neurotensin/neuromedin N | P30990 | 144-163 | Ile-Pro-Tyr-Ile-Leu-Lys-Arg-Gln-Leu-Tyr-Glu+Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu | P | MS | Gln | Leu | Tyr | Glu | Asn | Lys | Pro | Arg | Shinkai-Ouchi et al., 2016 | ||
| neurotensin/neuromedin N | P30990 | 144-163 | Ile-Pro-Tyr-Ile-Leu-Lys-Arg-Gln-Leu-Tyr+Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu | P | MS | Arg | Gln | Leu | Tyr | Glu | Asn | Lys | Pro | Shinkai-Ouchi et al., 2016 | ||
| neurotensin/neuromedin N | P30990 | 144-163 | Ile-Pro-Tyr-Ile-Leu-Lys-Arg-Gln-Leu+Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu | P | MS | Lys | Arg | Gln | Leu | Tyr | Glu | Asn | Lys | Shinkai-Ouchi et al., 2016 | ||
| neurotensin/neuromedin N | P30990 | 144-163 | Ile-Pro-Tyr-Ile-Leu-Lys+Arg-Gln-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu | P | MS | Tyr | Ile | Leu | Lys | Arg | Gln | Leu | Tyr | Shinkai-Ouchi et al., 2016 | ||
| neurotensin/neuromedin N | P30990 | 144-163 | Ile+Pro-Tyr-Ile-Leu-Lys-Arg-Gln-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu | P | MS | '-' | '-' | '-' | Ile | Pro | Tyr | Ile | Leu | Shinkai-Ouchi et al., 2016 | ||
| NF-kappa-B inhibitor alpha | P25963 | 1-317 | peptide-Gln50+Glu-peptide | P | Lys | Glu | Leu | Gln | Glu | Ile | Arg | Leu | Han et al., 1999 | 19383 | ||
| nF-kappa-B inhibitor alpha | P25963 | 43-60 | Glu-Gln-Met-Val-Lys-Glu-Leu-Gln-Glu-Ile-Arg-Leu-Glu-Pro-Gln-Glu+Val-Pro | P | MS | Glu | Pro | Gln | Glu | Val | Pro | '-' | '-' | Shinkai-Ouchi et al., 2016 | ||
| nF-kappa-B inhibitor alpha | P25963 | 41-60 | Glu-Tyr-Glu-Gln-Met-Val-Lys-Glu-Leu-Gln-Glu-Ile-Arg-Leu-Glu-Pro-Gln-Glu+Val-Pro | P | MS | Glu | Pro | Gln | Glu | Val | Pro | '-' | '-' | Shinkai-Ouchi et al., 2016 | ||
| nF-kappa-B inhibitor alpha | P25963 | 41-60 | Glu-Tyr-Glu-Gln-Met-Val-Lys-Glu-Leu-Gln-Glu-Ile-Arg-Leu-Glu-Pro-Gln+Glu-Val-Pro | P | MS | Leu | Glu | Pro | Gln | Glu | Val | Pro | '-' | Shinkai-Ouchi et al., 2016 | ||
| nF-kappa-B inhibitor alpha | P25963 | 41-60 | Glu-Tyr-Glu-Gln-Met-Val-Lys-Glu-Leu-Gln-Glu-Ile-Arg+Leu-Glu-Pro-Gln-Glu-Val-Pro | P | MS | Gln | Glu | Ile | Arg | Leu | Glu | Pro | Gln | Shinkai-Ouchi et al., 2016 | ||
| nF-kappa-B inhibitor alpha | P25963 | 41-60 | Glu-Tyr-Glu-Gln-Met-Val-Lys-Glu-Leu-Gln-Glu+Ile-Arg-Leu-Glu-Pro-Gln-Glu-Val-Pro | P | MS | Glu | Leu | Gln | Glu | Ile | Arg | Leu | Glu | Shinkai-Ouchi et al., 2016 | ||
| nF-kappa-B inhibitor alpha | P25963 | 42-60 | Tyr-Glu-Gln-Met-Val-Lys-Glu-Leu-Gln+Glu-Ile-Arg-Leu-Glu-Pro-Gln-Glu-Val-Pro | P | MS | Lys | Glu | Leu | Gln | Glu | Ile | Arg | Leu | Shinkai-Ouchi et al., 2016 | ||
| nF-kappa-B inhibitor alpha | P25963 | 45-60 | Met-Val-Lys-Glu-Leu-Gln-Glu-Ile-Arg-Leu-Glu-Pro-Gln-Glu+Val-Pro | P | MS | Glu | Pro | Gln | Glu | Val | Pro | '-' | '-' | Shinkai-Ouchi et al., 2016 | ||
| nF-kappa-B inhibitor alpha | P25963 | 45-60 | Met-Val-Lys-Glu-Leu-Gln-Glu-Ile-Arg+Leu-Glu-Pro-Gln-Glu-Val-Pro | P | MS | Gln | Glu | Ile | Arg | Leu | Glu | Pro | Gln | Shinkai-Ouchi et al., 2016 | ||
| nF-kappa-B inhibitor alpha | P25963 | 46-60 | Val-Lys-Glu-Leu-Gln-Glu-Ile-Arg+Leu-Glu-Pro-Gln-Glu-Val-Pro | P | MS | Gln | Glu | Ile | Arg | Leu | Glu | Pro | Gln | Shinkai-Ouchi et al., 2016 | ||
| nF-kappa-B inhibitor alpha | P25963 | 42-60 | Tyr-Glu-Gln-Met-Val-Lys-Glu-Leu-Gln-Glu-Ile-Arg+Leu-Glu-Pro-Gln-Glu-Val-Pro | P | MS | Gln | Glu | Ile | Arg | Leu | Glu | Pro | Gln | Shinkai-Ouchi et al., 2016 | ||
| nF-kappa-B inhibitor alpha | P25963 | 41-60 | Glu-Tyr-Glu-Gln-Met-Val-Lys-Glu-Leu-Gln+Glu-Ile-Arg-Leu-Glu-Pro-Gln-Glu-Val-Pro | P | MS | Lys | Glu | Leu | Gln | Glu | Ile | Arg | Leu | Shinkai-Ouchi et al., 2016 | ||
| peroxiredoxin-2 | P32119 | 173-192 | Pro-Ala-Gly-Trp-Lys-Pro-Gly-Ser-Asp-Thr-Ile-Lys-Pro+Asn-Val-Asp-Asp-Ser-Lys-Glu | P | MS | Thr | Ile | Lys | Pro | Asn | Val | Asp | Asp | Shinkai-Ouchi et al., 2016 | ||
| peroxiredoxin-2 | P32119 | 173-192 | Pro-Ala-Gly-Trp-Lys+Pro-Gly-Ser-Asp-Thr-Ile-Lys-Pro-Asn-Val-Asp-Asp-Ser-Lys-Glu | P | MS | Ala | Gly | Trp | Lys | Pro | Gly | Ser | Asp | Shinkai-Ouchi et al., 2016 | ||
| plasma membrane calcium-transporting ATPase 2 | Q01814 | 1126-1146 | peptide-Arg1142+Val-peptide | P | MS | Thr | Gln | Ile | Arg | Val | Val | Lys | Ala | Shinkai-Ouchi et al., 2016 | ||
| plasma membrane calcium-transporting ATPase 2 | Q01814 | 1126-1146 | peptide-Gln1138+Thr-peptide | P | MS | Asn | Arg | Ile | Gln | Thr | Gln | Ile | Arg | Shinkai-Ouchi et al., 2016 | ||
| plasma membrane calcium-transporting ATPase 2 | Q01814 | 1126-1146 | peptide-Asn1135+Arg-peptide | P | MS | Arg | Gly | Leu | Asn | Arg | Ile | Gln | Thr | Shinkai-Ouchi et al., 2016 | ||
| plasma membrane calcium-transporting ATPase 2 | Q01814 | 1128-1146 | Ile-Leu-Trp-Phe-Arg-Gly-Leu-Asn+Arg-Ile-Gln-Thr-Gln-Ile-Arg-Val-Val-Lys-Ala | P | MS | Arg | Gly | Leu | Asn | Arg | Ile | Gln | Thr | Shinkai-Ouchi et al., 2016 | ||
| poly [ADP-ribose] polymerase 1 | P09874 | 648-666 | Asp-Glu-Glu-Ala-Val-Lys-Lys-Leu-Thr-Val-Asn-Pro-Gly-Thr-Lys+Ser-Lys-Leu-Pro | P | MS | Pro | Gly | Thr | Lys | Ser | Lys | Leu | Pro | Shinkai-Ouchi et al., 2016 | ||
| poly [ADP-ribose] polymerase 1 | P09874 | 648-666 | Asp-Glu-Glu-Ala-Val-Lys-Lys-Leu-Thr-Val-Asn-Pro-Gly-Thr+Lys-Ser-Lys-Leu-Pro | P | MS | Asn | Pro | Gly | Thr | Lys | Ser | Lys | Leu | Shinkai-Ouchi et al., 2016 | ||
| poly [ADP-ribose] polymerase 1 | P09874 | 647-666 | Gln-Asp-Glu-Glu-Ala-Val-Lys-Lys-Leu-Thr-Val-Asn-Pro-Gly-Thr-Lys+Ser-Lys-Leu-Pro | P | MS | Pro | Gly | Thr | Lys | Ser | Lys | Leu | Pro | Shinkai-Ouchi et al., 2016 | ||
| poly [ADP-ribose] polymerase 1 | P09874 | 647-666 | Gln-Asp-Glu-Glu-Ala-Val-Lys-Lys-Leu-Thr-Val-Asn-Pro-Gly-Thr+Lys-Ser-Lys-Leu-Pro | P | MS | Asn | Pro | Gly | Thr | Lys | Ser | Lys | Leu | Shinkai-Ouchi et al., 2016 | ||
| poly [ADP-ribose] polymerase 1 | P09874 | 647-666 | Gln-Asp-Glu-Glu-Ala-Val-Lys-Lys-Leu-Thr+Val-Asn-Pro-Gly-Thr-Lys-Ser-Lys-Leu-Pro | P | MS | Lys | Lys | Leu | Thr | Val | Asn | Pro | Gly | Shinkai-Ouchi et al., 2016 | ||
| poly [ADP-ribose] polymerase 1 | P09874 | 647-666 | Gln-Asp-Glu+Glu-Ala-Val-Lys-Lys-Leu-Thr-Val-Asn-Pro-Gly-Thr-Lys-Ser-Lys-Leu-Pro | P | MS | '-' | Gln | Asp | Glu | Glu | Ala | Val | Lys | Shinkai-Ouchi et al., 2016 | ||
| poly [ADP-ribose] polymerase 1 | P18493 | 375-394 | Ser-Ala-Ala-Ser-Ala-Pro-Ala-Ala-Val-His-Ser-Gly-Pro-Pro-Asp-Lys-Pro-Leu-Ser+Asn | P | MS | Lys | Pro | Leu | Ser | Asn | '-' | '-' | '-' | Shinkai-Ouchi et al., 2016 | ||
| poly [ADP-ribose] polymerase 1 | P18493 | 375-394 | Ser-Ala-Ala-Ser-Ala-Pro-Ala-Ala-Val-His+Ser-Gly-Pro-Pro-Asp-Lys-Pro-Leu-Ser-Asn | P | MS | Ala | Ala | Val | His | Ser | Gly | Pro | Pro | Shinkai-Ouchi et al., 2016 | ||
| poly [ADP-ribose] polymerase 1 | P18493 | 375-394 | Ser-Ala-Ala-Ser-Ala+Pro-Ala-Ala-Val-His-Ser-Gly-Pro-Pro-Asp-Lys-Pro-Leu-Ser-Asn | P | MS | Ala | Ala | Ser | Ala | Pro | Ala | Ala | Val | Shinkai-Ouchi et al., 2016 | ||
| poly [ADP-ribose] polymerase 1 | P18493 | 375-394 | Ser-Ala-Ala+Ser-Ala-Pro-Ala-Ala-Val-His-Ser-Gly-Pro-Pro-Asp-Lys-Pro-Leu-Ser-Asn | P | MS | '-' | Ser | Ala | Ala | Ser | Ala | Pro | Ala | Shinkai-Ouchi et al., 2016 | ||
| poly [ADP-ribose] polymerase 1 | P18493 | 375-394 | Ser+Ala-Ala-Ser-Ala-Pro-Ala-Ala-Val-His-Ser-Gly-Pro-Pro-Asp-Lys-Pro-Leu-Ser-Asn | P | MS | '-' | '-' | '-' | Ser | Ala | Ala | Ser | Ala | Shinkai-Ouchi et al., 2016 | ||
| proenkephalin-B | P01213 | 203-222 | Leu-Tyr-Lys-Arg-Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys+Trp-Asp-Asn | P | MS | Pro | Lys | Leu | Lys | Trp | Asp | Asn | '-' | Shinkai-Ouchi et al., 2016 | ||
| proenkephalin-B | P01213 | 203-222 | Leu-Tyr-Lys-Arg-Tyr-Gly-Gly-Phe-Leu-Arg+Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn | P | MS | Gly | Phe | Leu | Arg | Arg | Ile | Arg | Pro | Shinkai-Ouchi et al., 2016 | ||
| proenkephalin-B | P01213 | 203-222 | Leu-Tyr-Lys-Arg-Tyr+Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn | P | MS | Tyr | Lys | Arg | Tyr | Gly | Gly | Phe | Leu | Shinkai-Ouchi et al., 2016 | ||
| progonadoliberin-1 | P13562 | 17-36 | Glu-Gly-Cys-Ser-Ser-Gln-His-Trp-Ser-Tyr-Gly-Leu+Arg-Pro-Gly-Gly-Lys-Arg-Asn-Thr | P | MS | Ser | Tyr | Gly | Leu | Arg | Pro | Gly | Gly | Shinkai-Ouchi et al., 2016 | ||
| progonadoliberin-1 | P13562 | 17-36 | Glu-Gly-Cys-Ser-Ser-Gln-His-Trp-Ser-Tyr-Gly+Leu-Arg-Pro-Gly-Gly-Lys-Arg-Asn-Thr | P | MS | Trp | Ser | Tyr | Gly | Leu | Arg | Pro | Gly | Shinkai-Ouchi et al., 2016 | ||
| progonadoliberin-1 | P13562 | 17-36 | Glu-Gly-Cys-Ser-Ser-Gln-His-Trp-Ser-Tyr+Gly-Leu-Arg-Pro-Gly-Gly-Lys-Arg-Asn-Thr | P | MS | His | Trp | Ser | Tyr | Gly | Leu | Arg | Pro | Shinkai-Ouchi et al., 2016 | ||
| protamine-YII | P69008 | 1-30 | peptide-Arg14+Arg-peptide | N | Pro | Val | Arg | Arg | Arg | Arg | Pro | Arg | Hayashi et al., 1985 | |||
| protamine-YII | P69008 | 1-30 | peptide-Arg22+Arg-peptide | N | Arg | Val | Ser | Arg | Arg | Arg | Arg | Ala | Hayashi et al., 1985 | |||
| protamine-Z | P69010 | 1-31 | peptide-Arg15+Arg-peptide | N | Pro | Val | Arg | Arg | Arg | Arg | Pro | Arg | Hayashi et al., 1985 | 20792 | ||
| protamine-Z | P69010 | 1-31 | peptide-Arg23+Arg-peptide | N | Arg | Val | Ser | Arg | Arg | Arg | Arg | Ala | Hayashi et al., 1985 | 20793 | ||
| protein kinase C alpha type | P05696 | 2-672 | peptide-Lys309+Leu-peptide | P | Glu | Lys | Ala | Lys | Leu | Gly | Pro | Ala | Kishimoto et al., 1989 | 26304 | ||
| protein kinase C alpha type | P17252 | 307-326 | Lys-Ala-Lys-Leu-Gly-Pro-Ala-Gly-Asn-Lys+Val-Ile-Ser-Pro-Ser-Glu-Asp-Arg-Lys-Gln | P | MS | Ala | Gly | Asn | Lys | Val | Ile | Ser | Pro | Shinkai-Ouchi et al., 2016 | ||
| protein kinase C alpha type | P17252 | 307-326 | Lys-Ala-Lys-Leu-Gly+Pro-Ala-Gly-Asn-Lys-Val-Ile-Ser-Pro-Ser-Glu-Asp-Arg-Lys-Gln | P | MS | Ala | Lys | Leu | Gly | Pro | Ala | Gly | Asn | Shinkai-Ouchi et al., 2016 | ||
| protein kinase C alpha type | P17252 | 307-326 | Lys+Ala-Lys-Leu-Gly-Pro-Ala-Gly-Asn-Lys-Val-Ile-Ser-Pro-Ser-Glu-Asp-Arg-Lys-Gln | P | MS | '-' | '-' | '-' | Lys | Ala | Lys | Leu | Gly | Shinkai-Ouchi et al., 2016 | ||
| protein kinase C beta type | P68403 | 2-671 | peptide-Gly311+Gln-peptide | P | Ala | Lys | Ile | Gly | Gln | Gly | Thr | Lys | Kishimoto et al., 1989 | 26308 | ||
| protein kinase C beta type | P68404 | 302-321 | Arg-Gln-Lys-Phe-Glu-Arg-Ala-Lys-Ile-Gly-Gln-Gly-Thr-Lys+Ala-Pro-Glu-Glu-Lys-Thr | P | MS | Gln | Gly | Thr | Lys | Ala | Pro | Glu | Glu | Shinkai-Ouchi et al., 2016 | ||
| protein kinase C beta type | P68404 | 302-321 | Arg-Gln-Lys-Phe-Glu-Arg-Ala-Lys-Ile-Gly-Gln-Gly-Thr+Lys-Ala-Pro-Glu-Glu-Lys-Thr | P | MS | Gly | Gln | Gly | Thr | Lys | Ala | Pro | Glu | Shinkai-Ouchi et al., 2016 | ||
| protein kinase C beta type | P68404 | 302-321 | Arg-Gln-Lys-Phe-Glu-Arg-Ala-Lys-Ile-Gly-Gln-Gly+Thr-Lys-Ala-Pro-Glu-Glu-Lys-Thr | P | MS | Ile | Gly | Gln | Gly | Thr | Lys | Ala | Pro | Shinkai-Ouchi et al., 2016 | ||
| protein kinase C beta type | P68404 | 302-321 | Arg-Gln-Lys-Phe-Glu-Arg-Ala-Lys-Ile-Gly+Gln-Gly-Thr-Lys-Ala-Pro-Glu-Glu-Lys-Thr | P | MS | Ala | Lys | Ile | Gly | Gln | Gly | Thr | Lys | Shinkai-Ouchi et al., 2016 | ||
| protein kinase C gamma type | P63319 | 1-697 | peptide-Ser321+Ser-peptide | P | Gly | Pro | Ser | Ser | Ser | Pro | Ile | Pro | Kishimoto et al., 1989 | 26312 | ||
| protein kinase C gamma type | P63319 | 1-697 | peptide-Phe338+Phe-peptide | P | Lys | Arg | Cys | Phe | Phe | Gly | Ala | Ser | Kishimoto et al., 1989 | 26313 | ||
| protein kinase C gamma type | P05129 | 312-331 | Tyr-Glu-Arg-Val-Arg-Met-Gly-Pro-Ser-Ser-Ser-Pro-Ile-Pro-Ser-Pro-Ser-Pro-Ser+Pro | P | MS | Pro | Ser | Pro | Ser | Pro | '-' | '-' | '-' | Shinkai-Ouchi et al., 2016 | ||
| protein kinase C gamma type | P05129 | 312-331 | Tyr-Glu-Arg-Val-Arg-Met-Gly-Pro-Ser-Ser+Ser-Pro-Ile-Pro-Ser-Pro-Ser-Pro-Ser-Pro | P | MS | Gly | Pro | Ser | Ser | Ser | Pro | Ile | Pro | Shinkai-Ouchi et al., 2016 | ||
| protein kinase C gamma type | P05129 | 312-331 | Tyr-Glu-Arg-Val-Arg-Met-Gly-Pro-Ser+Ser-Ser-Pro-Ile-Pro-Ser-Pro-Ser-Pro-Ser-Pro | P | MS | Met | Gly | Pro | Ser | Ser | Ser | Pro | Ile | Shinkai-Ouchi et al., 2016 | ||
| protein kinase C gamma type | P05129 | 312-331 | Tyr-Glu-Arg-Val-Arg+Met-Gly-Pro-Ser-Ser-Ser-Pro-Ile-Pro-Ser-Pro-Ser-Pro-Ser-Pro | P | MS | Glu | Arg | Val | Arg | Met | Gly | Pro | Ser | Shinkai-Ouchi et al., 2016 | ||
| proteinase-activated receptor 2 | P55085 | 26-397 | peptide-Thr45+Ser-peptide | N | Val | Asp | Gly | Thr | Ser | His | Val | Thr | Loew et al., 2000 | 26215 | ||
| proteinase-activated receptor 2 | P55085 | 26-397 | peptide-Val58+Phe-peptide | N | Val | Glu | Thr | Val | Phe | Ser | Val | Asp | Loew et al., 2000 | 26214 | ||
| proteinase-activated receptor 2 | P55085 | 26-397 | peptide-Gly71+Lys-peptide | N | Val | Leu | Thr | Gly | Lys | Leu | Thr | Thr | Loew et al., 2000 | 26216 | ||
| proto-oncogene c-Fos | P01101 | 81-100 | Leu-Val-Ser-Ser-Val-Ala-Pro-Ser-Gln-Thr-Arg+Ala-Pro-His-Pro-Tyr-Gly-Leu-Pro-Thr | P | MS | Ser | Gln | Thr | Arg | Ala | Pro | His | Pro | Shinkai-Ouchi et al., 2016 | ||
| proto-oncogene c-Fos | P01101 | 81-100 | Leu-Val-Ser-Ser-Val-Ala-Pro-Ser-Gln-Thr+Arg-Ala-Pro-His-Pro-Tyr-Gly-Leu-Pro-Thr | P | MS | Pro | Ser | Gln | Thr | Arg | Ala | Pro | His | Shinkai-Ouchi et al., 2016 | ||
| proto-oncogene c-Fos | P01101 | 81-100 | Leu-Val-Ser+Ser-Val-Ala-Pro-Ser-Gln-Thr-Arg-Ala-Pro-His-Pro-Tyr-Gly-Leu-Pro-Thr | P | MS | '-' | Leu | Val | Ser | Ser | Val | Ala | Pro | Shinkai-Ouchi et al., 2016 | ||
| RB1 retinoblastoma 1 | P06400 | 768-928 | peptide-Lys810+Ser-peptide | N | Ser | Pro | Leu | Lys | Ser | Pro | Tyr | Lys | Darnell et al., 2007 | 20883 | ||
| receptor-type tyrosine-protein phosphatase-like N | Q16849 | 599-618 | Cys-Val-Arg-Gln-His-Ala-Arg-Gln-Gln-Asp+Lys-Glu-Arg-Leu-Ala-Ala-Leu-Gly-Pro-Glu | P | MS | Arg | Gln | Gln | Asp | Lys | Glu | Arg | Leu | Shinkai-Ouchi et al., 2016 | ||
| receptor-type tyrosine-protein phosphatase-like N | Q16849 | 599-618 | Cys+Val-Arg-Gln-His-Ala-Arg-Gln-Gln-Asp-Lys-Glu-Arg-Leu-Ala-Ala-Leu-Gly-Pro-Glu | P | MS | '-' | '-' | '-' | Cys | Val | Arg | Gln | His | Shinkai-Ouchi et al., 2016 | ||
| receptor-type tyrosine-protein phosphatase-like N | Q16849 | 600-618 | Val-Arg-Gln-His-Ala-Arg-Gln-Gln-Asp-Lys-Glu-Arg-Leu-Ala+Ala-Leu-Gly-Pro-Glu | P | MS | Glu | Arg | Leu | Ala | Ala | Leu | Gly | Pro | Shinkai-Ouchi et al., 2016 | ||
| receptor-type tyrosine-protein phosphatase-like N | Q16849 | 600-618 | Val-Arg-Gln-His-Ala-Arg-Gln-Gln-Asp+Lys-Glu-Arg-Leu-Ala-Ala-Leu-Gly-Pro-Glu | P | MS | Arg | Gln | Gln | Asp | Lys | Glu | Arg | Leu | Shinkai-Ouchi et al., 2016 | ||
| receptor-type tyrosine-protein phosphatase-like N | Q16849 | 649-668 | Pro-Glu-Pro-Ser-Arg-Val-Ser-Ser-Val-Ser-Ser-Gln-Phe+Ser-Asp-Ala-Ala-Gln-Ala-Ser | P | MS | Ser | Ser | Gln | Phe | Ser | Asp | Ala | Ala | Shinkai-Ouchi et al., 2016 | ||
| receptor-type tyrosine-protein phosphatase-like N | Q16849 | 649-668 | Pro-Glu-Pro-Ser-Arg-Val-Ser-Ser-Val-Ser-Ser-Gln+Phe-Ser-Asp-Ala-Ala-Gln-Ala-Ser | P | MS | Val | Ser | Ser | Gln | Phe | Ser | Asp | Ala | Shinkai-Ouchi et al., 2016 | ||
| receptor-type tyrosine-protein phosphatase-like N | Q16849 | 649-668 | Pro-Glu-Pro-Ser-Arg-Val-Ser-Ser-Val-Ser-Ser+Gln-Phe-Ser-Asp-Ala-Ala-Gln-Ala-Ser | P | MS | Ser | Val | Ser | Ser | Gln | Phe | Ser | Asp | Shinkai-Ouchi et al., 2016 | ||
| receptor-type tyrosine-protein phosphatase-like N | Q16849 | 649-668 | Pro-Glu-Pro-Ser-Arg-Val-Ser-Ser-Val-Ser+Ser-Gln-Phe-Ser-Asp-Ala-Ala-Gln-Ala-Ser | P | MS | Ser | Ser | Val | Ser | Ser | Gln | Phe | Ser | Shinkai-Ouchi et al., 2016 | ||
| ryanodine receptor 1 | P11716 | 1391-1410 | Phe-Lys-Ala-Lys-Lys-Ala-Ala-Met-Met-Thr-Gln+Pro-Pro-Ala-Thr-Pro-Ala-Leu-Pro-Arg | P | MS | Met | Met | Thr | Gln | Pro | Pro | Ala | Thr | Shinkai-Ouchi et al., 2016 | ||
| ryanodine receptor 1 | P11716 | 1391-1410 | Phe-Lys-Ala-Lys-Lys-Ala-Ala-Met-Met-Thr+Gln-Pro-Pro-Ala-Thr-Pro-Ala-Leu-Pro-Arg | P | MS | Ala | Met | Met | Thr | Gln | Pro | Pro | Ala | Shinkai-Ouchi et al., 2016 | ||
| ryanodine receptor 1 | P11716 | 1391-1410 | Phe-Lys-Ala-Lys-Lys-Ala-Ala-Met-Met+Thr-Gln-Pro-Pro-Ala-Thr-Pro-Ala-Leu-Pro-Arg | P | MS | Ala | Ala | Met | Met | Thr | Gln | Pro | Pro | Shinkai-Ouchi et al., 2016 | ||
| ryanodine receptor 1 | P11716 | 2834-2853 | Thr-Glu-Lys-Lys-Lys-Thr-Arg-Lys-Ile-Ser-Gln-Thr-Ala+Gln-Thr-Tyr-Asp-Pro-Arg-Glu | P | MS | Ser | Gln | Thr | Ala | Gln | Thr | Tyr | Asp | Shinkai-Ouchi et al., 2016 | ||
| ryanodine receptor 1 | P11716 | 2834-2853 | Thr-Glu-Lys-Lys-Lys-Thr-Arg-Lys-Ile-Ser-Gln-Thr+Ala-Gln-Thr-Tyr-Asp-Pro-Arg-Glu | P | MS | Ile | Ser | Gln | Thr | Ala | Gln | Thr | Tyr | Shinkai-Ouchi et al., 2016 | ||
| ryanodine receptor 1 | P11716 | 2834-2853 | Thr-Glu-Lys-Lys-Lys-Thr-Arg-Lys-Ile-Ser+Gln-Thr-Ala-Gln-Thr-Tyr-Asp-Pro-Arg-Glu | P | MS | Arg | Lys | Ile | Ser | Gln | Thr | Ala | Gln | Shinkai-Ouchi et al., 2016 | ||
| ryanodine receptor 1 | P11716 | 2834-2853 | Thr-Glu-Lys-Lys-Lys-Thr-Arg+Lys-Ile-Ser-Gln-Thr-Ala-Gln-Thr-Tyr-Asp-Pro-Arg-Glu | P | MS | Lys | Lys | Thr | Arg | Lys | Ile | Ser | Gln | Shinkai-Ouchi et al., 2016 | ||
| ryanodine receptor 1 | P11716 | 2834-2853 | Thr-Glu-Lys-Lys-Lys-Thr+Arg-Lys-Ile-Ser-Gln-Thr-Ala-Gln-Thr-Tyr-Asp-Pro-Arg-Glu | P | MS | Lys | Lys | Lys | Thr | Arg | Lys | Ile | Ser | Shinkai-Ouchi et al., 2016 | ||
| SAG S-antigen | P08168 | 1-404 | peptide-Leu385+Lys-peptide | P | Arg | Gln | Asn | Leu | Lys | Asp | Ala | Gly | Azarian et al., 1995 | 26314 | ||
| SAG S-antigen | P08168 | 1-404 | peptide-Phe380+Ala-peptide | P | Phe | Glu | Glu | Phe | Ala | Arg | Gln | Asn | Azarian et al., 1995 | 26315 | ||
| selenoprotein K | Q9Y6D0 | 2-94 | peptide-Arg81+Gly-peptide | P | NT | Asn | His | Leu | Arg | Gly | Pro | Ser | Pro | Huang et al., 2011 | ||
| selenoprotein K fragment (Cys-92) | Q9Y6D0 | 65-94 | peptide-Arg81+Gly-peptide | S | NT | Asn | His | Leu | Arg | Gly | Pro | Ser | Pro | Huang et al., 2011 | ||
| SLC6A3 solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | Q01959 | 1-620 | peptide-Thr43+Ser-peptide | P | Val | Gln | Leu | Thr | Ser | Ser | Thr | Leu | Franekova et al., 2008 | 20876 | ||
| SLC6A3 solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | Q01959 | 1-620 | peptide-Leu71+Ser-peptide | P | Asp | Phe | Leu | Leu | Ser | Val | Ile | Gly | Franekova et al., 2008 | 20877 | ||
| Somatostatin | P61278 | 103-116 | Peptide-Thr112+Phe-Ser-Cys | N | Phe | Trp | Lys | Thr | Phe | Ser | Cys | - | McDermott et al., 1985 | |||
| spectrin alpha chain, non-erythrocytic 1 | Q13813 | 1167-1186 | Val-Gln-Ala-Val-Gln-Gln-Gln-Glu-Val-Tyr-Gly+Met-Met-Pro-Arg-Asp-Glu-Thr-Asp-Ser | P | MS | Glu | Val | Tyr | Gly | Met | Met | Pro | Arg | Shinkai-Ouchi et al., 2016 | ||
| spectrin alpha chain, non-erythrocytic 1 | Q13813 | 1167-1186 | Val-Gln-Ala-Val-Gln-Gln-Gln-Glu-Val-Tyr+Gly-Met-Met-Pro-Arg-Asp-Glu-Thr-Asp-Ser | P | MS | Gln | Glu | Val | Tyr | Gly | Met | Met | Pro | Shinkai-Ouchi et al., 2016 | ||
| spectrin beta chain, erythrocytic | P11277 | 2053-2068 | Ala-Phe-Glu-Lys-Ser-Thr-Ala-Ser-Trp+Ala-Glu-Arg-Phe-Ala-Ala-Leu | P | MS | Thr | Ala | Ser | Trp | Ala | Glu | Arg | Phe | Shinkai-Ouchi et al., 2016 | ||
| spectrin beta chain, erythrocytic | P11277 | 2049-2068 | Lys-Arg-His-Glu-Ala-Phe-Glu-Lys-Ser-Thr-Ala-Ser-Trp+Ala-Glu-Arg-Phe-Ala-Ala-Leu | P | MS | Thr | Ala | Ser | Trp | Ala | Glu | Arg | Phe | Shinkai-Ouchi et al., 2016 | ||
| spectrin beta chain, erythrocytic | P11277 | 2049-2068 | Lys-Arg-His-Glu-Ala-Phe-Glu-Lys-Ser-Thr-Ala+Ser-Trp-Ala-Glu-Arg-Phe-Ala-Ala-Leu | P | MS | Lys | Ser | Thr | Ala | Ser | Trp | Ala | Glu | Shinkai-Ouchi et al., 2016 | ||
| spectrin beta chain, erythrocytic | P11277 | 2049-2068 | Lys-Arg-His-Glu-Ala-Phe-Glu-Lys-Ser-Thr+Ala-Ser-Trp-Ala-Glu-Arg-Phe-Ala-Ala-Leu | P | MS | Glu | Lys | Ser | Thr | Ala | Ser | Trp | Ala | Shinkai-Ouchi et al., 2016 | ||
| spectrin beta chain, erythrocytic | P11277 | 2049-2068 | Lys-Arg-His-Glu-Ala-Phe-Glu-Lys+Ser-Thr-Ala-Ser-Trp-Ala-Glu-Arg-Phe-Ala-Ala-Leu | P | MS | Ala | Phe | Glu | Lys | Ser | Thr | Ala | Ser | Shinkai-Ouchi et al., 2016 | ||
| src substrate cortactin | Q14247 | 1-550 | peptide-Lys336+Thr-peptide | P | Ala | Tyr | Gln | Lys | Thr | Val | Pro | Val | Perrin et al., 2006 | 18044 | ||
| src substrate cortactin | Q14247 | 1-550 | peptide-Lys346+Thr-peptide | P | Val | Thr | Ser | Lys | Thr | Ser | Asn | Ile | Perrin et al., 2006 | 18047 | ||
| src substrate cortactin | Q14247 | 1-550 | peptide-Arg351+Ala-peptide | P | Ser | Asn | Ile | Arg | Ala | Asn | Phe | Glu | Perrin et al., 2006 | 18048 | ||
| src substrate cortactin | Q14247 | 1-550 | peptide-Ala358+Lys-peptide | P | Glu | Asn | Leu | Ala | Lys | Glu | Lys | Glu | Perrin et al., 2006 | |||
| src substrate cortactin | Q14247 | 339-356 | Pro-Val-Glu-Ala-Val-Thr-Ser-Lys-Thr-Ser-Asn-Ile-Arg+Ala-Asn-Phe-Glu-Asn | P | MS | Ser | Asn | Ile | Arg | Ala | Asn | Phe | Glu | Shinkai-Ouchi et al., 2016 | ||
| src substrate cortactin | Q14247 | 339-356 | Pro-Val-Glu-Ala-Val-Thr-Ser-Lys+Thr-Ser-Asn-Ile-Arg-Ala-Asn-Phe-Glu-Asn | P | MS | Val | Thr | Ser | Lys | Thr | Ser | Asn | Ile | Shinkai-Ouchi et al., 2016 | ||
| src substrate cortactin | Q14247 | 337-356 | Thr-Val-Pro-Val-Glu-Ala-Val-Thr-Ser-Lys-Thr-Ser-Asn-Ile-Arg+Ala-Asn-Phe-Glu-Asn | P | MS | Ser | Asn | Ile | Arg | Ala | Asn | Phe | Glu | Shinkai-Ouchi et al., 2016 | ||
| src substrate cortactin | Q14247 | 337-356 | Thr-Val-Pro-Val-Glu-Ala-Val-Thr-Ser-Lys-Thr-Ser+Asn-Ile-Arg-Ala-Asn-Phe-Glu-Asn | P | MS | Ser | Lys | Thr | Ser | Asn | Ile | Arg | Ala | Shinkai-Ouchi et al., 2016 | ||
| src substrate cortactin | Q14247 | 337-356 | Thr-Val-Pro-Val-Glu-Ala-Val-Thr-Ser-Lys+Thr-Ser-Asn-Ile-Arg-Ala-Asn-Phe-Glu-Asn | P | MS | Val | Thr | Ser | Lys | Thr | Ser | Asn | Ile | Shinkai-Ouchi et al., 2016 | ||
| src substrate cortactin | Q14247 | 337-356 | Thr-Val+Pro-Val-Glu-Ala-Val-Thr-Ser-Lys-Thr-Ser-Asn-Ile-Arg-Ala-Asn-Phe-Glu-Asn | P | MS | '-' | '-' | Thr | Val | Pro | Val | Glu | Ala | Shinkai-Ouchi et al., 2016 | ||
| src substrate cortactin | Q14247 | 337-356 | Thr+Val-Pro-Val-Glu-Ala-Val-Thr-Ser-Lys-Thr-Ser-Asn-Ile-Arg-Ala-Asn-Phe-Glu-Asn | P | MS | '-' | '-' | '-' | Thr | Val | Pro | Val | Glu | Shinkai-Ouchi et al., 2016 | ||
| src substrate cortactin | Q14247 | 338-356 | Val-Pro-Val-Glu-Ala-Val-Thr-Ser-Lys-Thr-Ser-Asn-Ile-Arg+Ala-Asn-Phe-Glu-Asn | P | MS | Ser | Asn | Ile | Arg | Ala | Asn | Phe | Glu | Shinkai-Ouchi et al., 2016 | ||
| Substance P | P20366 | 58-68 | Peptide-Met68+NH2 | N | Phe | Gly | Leu | Met | NH2 | - | - | - | McDermott et al., 1985 | |||
| Suc-Leu-Leu-Val-Tyr-NHMec | Suc-Leu-Leu-Val-Tyr+AMC | S | Leu | Leu | Val | Tyr | AMC | - | - | - | Wang et al., 1996 | |||||
| talin-1 | Q9Y490 | 424-443 | Val-Ser-Pro-Lys-Lys-Ser-Thr-Val-Leu-Gln-Gln+Gln-Tyr-Asn-Arg-Val-Gly-Lys-Val-Glu | P | MS | Val | Leu | Gln | Gln | Gln | Tyr | Asn | Arg | Shinkai-Ouchi et al., 2016 | ||
| talin-1 | Q9Y490 | 424-443 | Val-Ser-Pro-Lys-Lys-Ser-Thr-Val-Leu-Gln+Gln-Gln-Tyr-Asn-Arg-Val-Gly-Lys-Val-Glu | P | MS | Thr | Val | Leu | Gln | Gln | Gln | Tyr | Asn | Shinkai-Ouchi et al., 2016 | ||
| transcription factor AP-1 | P05412 | 53-72 | Leu-Arg-Ala-Lys-Asn-Ser-Asp-Leu-Leu-Thr-Ser-Pro-Asp-Val-Gly-Leu-Leu-Lys+Leu-Ala | P | MS | Gly | Leu | Leu | Lys | Leu | Ala | '-' | '-' | Shinkai-Ouchi et al., 2016 | ||
| transcription factor AP-1 | P05412 | 53-72 | Leu-Arg-Ala-Lys-Asn-Ser-Asp-Leu-Leu-Thr-Ser-Pro-Asp-Val-Gly+Leu-Leu-Lys-Leu-Ala | P | MS | Pro | Asp | Val | Gly | Leu | Leu | Lys | Leu | Shinkai-Ouchi et al., 2016 | ||
| transcription factor AP-1 | P05412 | 53-72 | Leu-Arg-Ala-Lys-Asn-Ser-Asp-Leu-Leu-Thr-Ser-Pro+Asp-Val-Gly-Leu-Leu-Lys-Leu-Ala | P | MS | Leu | Thr | Ser | Pro | Asp | Val | Gly | Leu | Shinkai-Ouchi et al., 2016 | ||
| transcription factor AP-1 | P05412 | 53-72 | Leu-Arg-Ala-Lys-Asn-Ser-Asp-Leu-Leu-Thr+Ser-Pro-Asp-Val-Gly-Leu-Leu-Lys-Leu-Ala | P | MS | Asp | Leu | Leu | Thr | Ser | Pro | Asp | Val | Shinkai-Ouchi et al., 2016 | ||
| transcription factor AP-1 | P05412 | 53-72 | Leu-Arg-Ala-Lys-Asn-Ser-Asp-Leu-Leu+Thr-Ser-Pro-Asp-Val-Gly-Leu-Leu-Lys-Leu-Ala | P | MS | Ser | Asp | Leu | Leu | Thr | Ser | Pro | Asp | Shinkai-Ouchi et al., 2016 | ||
| transforming protein RhoA | P61586 | 172-190 | Glu-Met-Ala-Thr-Arg-Ala-Ala-Leu-Gln-Ala-Arg+Arg-Gly-Lys-Lys-Lys-Ser-Gly-Cys | P | MS | Leu | Gln | Ala | Arg | Arg | Gly | Lys | Lys | Shinkai-Ouchi et al., 2016 | ||
| transforming protein RhoA | P61586 | 172-190 | Glu-Met-Ala-Thr-Arg-Ala-Ala-Leu-Gln-Ala+Arg-Arg-Gly-Lys-Lys-Lys-Ser-Gly-Cys | P | MS | Ala | Leu | Gln | Ala | Arg | Arg | Gly | Lys | Shinkai-Ouchi et al., 2016 | ||
| transforming protein RhoA | P61586 | 171-190 | Phe-Glu-Met-Ala-Thr-Arg-Ala-Ala-Leu-Gln-Ala-Arg+Arg-Gly-Lys-Lys-Lys-Ser-Gly-Cys | P | MS | Leu | Gln | Ala | Arg | Arg | Gly | Lys | Lys | Shinkai-Ouchi et al., 2016 | ||
| transforming protein RhoA | P61586 | 171-190 | Phe-Glu-Met-Ala-Thr-Arg-Ala-Ala-Leu-Gln-Ala+Arg-Arg-Gly-Lys-Lys-Lys-Ser-Gly-Cys | P | MS | Ala | Leu | Gln | Ala | Arg | Arg | Gly | Lys | Shinkai-Ouchi et al., 2016 | ||
| transforming protein RhoA | P61586 | 171-190 | Phe-Glu-Met-Ala-Thr-Arg-Ala-Ala-Leu-Gln+Ala-Arg-Arg-Gly-Lys-Lys-Lys-Ser-Gly-Cys | P | MS | Ala | Ala | Leu | Gln | Ala | Arg | Arg | Gly | Shinkai-Ouchi et al., 2016 | ||
| transforming protein RhoA | P61586 | 171-190 | Phe-Glu-Met+Ala-Thr-Arg-Ala-Ala-Leu-Gln-Ala-Arg-Arg-Gly-Lys-Lys-Lys-Ser-Gly-Cys | P | MS | '-' | Phe | Glu | Met | Ala | Thr | Arg | Ala | Shinkai-Ouchi et al., 2016 | ||
| tropomyosin alpha-1 chain | P58772 | 1-284 | peptide-Lys12+Leu-peptide | P | Gln | Met | Leu | Lys | Leu | Asp | Lys | Glu | Goll et al., 2003 | 20777 | ||
| tropomyosin alpha-1 chain | P58772 | 1-284 | peptide-Ala27+Asp-peptide | P | Gln | Ala | Glu | Ala | Asp | Lys | Lys | Ala | Goll et al., 2003 | 20778 | ||
| tropomyosin alpha-1 chain | P58772 | 1-284 | peptide-Ala183+Glu-peptide | P | Glu | Glu | Arg | Ala | Glu | Leu | Ser | Glu | Goll et al., 2003 | 20779 | ||
| tropomyosin alpha-1 chain | P58772 | 1-284 | peptide-Leu204+Lys-peptide | P | Thr | Asn | Asn | Leu | Lys | Ser | Leu | Glu | Goll et al., 2003 | 20780 | ||
| tropomyosin alpha-1 chain | P58772 | 1-284 | peptide-Lys205+Ser-peptide | P | Asn | Asn | Leu | Lys | Ser | Leu | Glu | Ala | Goll et al., 2003 | 20781 | ||
| tropomyosin alpha-1 chain | P58772 | 1-284 | peptide-Glu208+Ala-peptide | P | Lys | Ser | Leu | Glu | Ala | Gln | Ala | Glu | Goll et al., 2003 | 20782 | ||
| tropomyosin alpha-1 chain | P58772 | 1-284 | peptide-Glu223+Glu-peptide | P | Lys | Tyr | Glu | Glu | Glu | Ile | Lys | Val | Goll et al., 2003 | 20783 | ||
| tropomyosin alpha-1 chain | P58772 | 1-284 | peptide-Phe241+Ala-peptide | P | Arg | Ala | Glu | Phe | Ala | Glu | Arg | Ser | Goll et al., 2003 | 20784 | ||
| tropomyosin alpha-1 chain | P58772 | 1-284 | peptide-Leu256+Glu-peptide | P | Ile | Asp | Asp | Leu | Glu | Asp | Glu | Leu | Goll et al., 2003 | 20785 | ||
| tropomyosin alpha-1 chain | P58772 | 1-284 | peptide-Glu212+Lys-peptide | P | Ala | Gln | Ala | Glu | Lys | Tyr | Ser | Gln | Goll et al., 2003 | |||
| tropomyosin alpha-1 chain | P58772 | 1-284 | peptide-Asp219+Lys-peptide | P | Gln | Lys | Glu | Asp | Lys | Tyr | Glu | Glu | Goll et al., 2003 | |||
| troponin T, cardiac muscle | P50752 | 72-91 | Val-Glu-Asp-Thr-Lys-Pro-Lys-Pro-Ser-Arg-Leu-Phe-Met-Pro-Asn-Leu+Val-Pro-Pro-Lys | P | MS | Met | Pro | Asn | Leu | Val | Pro | Pro | Lys | Shinkai-Ouchi et al., 2016 | ||
| troponin T, cardiac muscle | P50752 | 72-91 | Val-Glu-Asp-Thr-Lys-Pro-Lys-Pro-Ser-Arg-Leu-Phe-Met-Pro-Asn+Leu-Val-Pro-Pro-Lys | P | MS | Phe | Met | Pro | Asn | Leu | Val | Pro | Pro | Shinkai-Ouchi et al., 2016 | ||
| troponin T, cardiac muscle | P50752 | 72-91 | Val-Glu-Asp-Thr-Lys-Pro-Lys-Pro-Ser-Arg-Leu-Phe+Met-Pro-Asn-Leu-Val-Pro-Pro-Lys | P | MS | Ser | Arg | Leu | Phe | Met | Pro | Asn | Leu | Shinkai-Ouchi et al., 2016 | ||
| troponin T, fast skeletal muscle | P45378 | 46-65 | Glu-Glu-Glu-Lys-Pro-Arg-Pro-Lys-Leu-Thr-Ala-Pro-Lys-Ile+Pro-Glu-Gly-Glu-Lys-Val | P | MS | Ala | Pro | Lys | Ile | Pro | Glu | Gly | Glu | Shinkai-Ouchi et al., 2016 | ||
| troponin T, fast skeletal muscle | P45378 | 46-65 | Glu-Glu-Glu-Lys-Pro-Arg-Pro-Lys-Leu-Thr+Ala-Pro-Lys-Ile-Pro-Glu-Gly-Glu-Lys-Val | P | MS | Pro | Lys | Leu | Thr | Ala | Pro | Lys | Ile | Shinkai-Ouchi et al., 2016 | ||
| troponin T, fast skeletal muscle | P45378 | 46-65 | Glu-Glu+Glu-Lys-Pro-Arg-Pro-Lys-Leu-Thr-Ala-Pro-Lys-Ile-Pro-Glu-Gly-Glu-Lys-Val | P | MS | '-' | '-' | Glu | Glu | Glu | Lys | Pro | Arg | Shinkai-Ouchi et al., 2016 | ||
| tyrosine hydroxylase | Q16846 | 17-32 | Ala-Val-Ser-Glu-Leu-Asp-Ala-Lys-Gln-Ala-Glu-Ala-Ile-Met+Ser-Pro | P | MS | Glu | Ala | Ile | Met | Ser | Pro | '-' | '-' | Shinkai-Ouchi et al., 2016 | ||
| tyrosine hydroxylase | Q16846 | 13-32 | Gly-Phe-Arg-Arg-Ala-Val-Ser-Glu-Leu-Asp-Ala-Lys-Gln-Ala-Glu+Ala-Ile-Met-Ser-Pro | P | MS | Lys | Gln | Ala | Glu | Ala | Ile | Met | Ser | Shinkai-Ouchi et al., 2016 | ||
| tyrosine hydroxylase | Q16846 | 13-32 | Gly-Phe-Arg-Arg-Ala-Val-Ser-Glu-Leu-Asp+Ala-Lys-Gln-Ala-Glu-Ala-Ile-Met-Ser-Pro | P | MS | Ser | Glu | Leu | Asp | Ala | Lys | Gln | Ala | Shinkai-Ouchi et al., 2016 | ||
| tyrosine hydroxylase | Q16846 | 13-32 | Gly-Phe-Arg-Arg-Ala-Val-Ser+Glu-Leu-Asp-Ala-Lys-Gln-Ala-Glu-Ala-Ile-Met-Ser-Pro | P | MS | Arg | Ala | Val | Ser | Glu | Leu | Asp | Ala | Shinkai-Ouchi et al., 2016 | ||
| unconventional myosin-Va | Q02440 | 1131-1150 | Ile-Thr-Glu-Ala-Glu-Asp-Leu-Pro-Leu-Arg-Met+Glu-Glu-Pro-Ser-Glu-Lys-Lys-Ala-Pro | P | MS | Pro | Leu | Arg | Met | Glu | Glu | Pro | Ser | Shinkai-Ouchi et al., 2016 | ||
| unconventional myosin-Va | Q02440 | 1131-1150 | Ile-Thr-Glu-Ala-Glu-Asp-Leu-Pro-Leu-Arg+Met-Glu-Glu-Pro-Ser-Glu-Lys-Lys-Ala-Pro | P | MS | Leu | Pro | Leu | Arg | Met | Glu | Glu | Pro | Shinkai-Ouchi et al., 2016 | ||
| vimentin | P20152 | 2-466 | peptide-Arg71+Ser-peptide | P | Val | Arg | Leu | Arg | Ser | Ser | Val | Pro | Fischer et al., 1986 | 26412 | ||
| vimentin | P20152 | 2-466 | peptide-Gly19+Thr-peptide | P | Gly | Gly | Ser | Gly | Thr | Ser | Ser | Arg | Fischer et al., 1986 | 26411 | ||
| vimentin | P20152 | 2-466 | peptide-Ser21+Ser-peptide | P | Ser | Gly | Thr | Ser | Ser | Arg | Pro | Ser | Fischer et al., 1986 | 26413 | ||
| vimentin | P20152 | 2-466 | peptide-Thr33+Ser-peptide | P | Tyr | Val | Thr | Thr | Ser | Thr | Arg | Thr | Fischer et al., 1986 | 26414 | ||
| vimentin | P20152 | 2-466 | peptide-Tyr38+Ser-peptide | P | Thr | Arg | Thr | Tyr | Ser | Leu | Gly | Ser | Fischer et al., 1986 | 26415 | ||
| vimentin | P20152 | 2-466 | peptide-Gly41+Ser-peptide | P | Tyr | Ser | Leu | Gly | Ser | Ala | Leu | Arg | Fischer et al., 1986 | 26416 | ||
| vimentin | P20152 | 2-466 | peptide-Tyr53+Ser-peptide | P | Arg | Ser | Leu | Tyr | Ser | Ser | Ser | Pro | Fischer et al., 1986 | 26417 | ||
| vimentin | P20152 | 2-466 | peptide-Arg64+Ser-peptide | P | Tyr | Val | Thr | Arg | Ser | Ser | Ala | Val | Fischer et al., 1986 | 26418 | ||
| vimentin | P08670 | 256-274 | Ile-Asp-Val-Asp-Val-Ser-Lys-Pro-Asp-Leu-Thr+Ala-Ala-Leu-Arg-Asp-Val-Arg-Gln | P | MS | Pro | Asp | Leu | Thr | Ala | Ala | Leu | Arg | Shinkai-Ouchi et al., 2016 | ||
| vimentin | P08670 | 255-274 | Gln-Ile-Asp-Val-Asp-Val-Ser-Lys-Pro-Asp-Leu-Thr-Ala-Ala-Leu-Arg+Asp-Val-Arg-Gln | P | MS | Ala | Ala | Leu | Arg | Asp | Val | Arg | Gln | Shinkai-Ouchi et al., 2016 | ||
| vimentin | P08670 | 255-274 | Gln-Ile-Asp-Val-Asp-Val-Ser-Lys-Pro-Asp-Leu-Thr-Ala+Ala-Leu-Arg-Asp-Val-Arg-Gln | P | MS | Asp | Leu | Thr | Ala | Ala | Leu | Arg | Asp | Shinkai-Ouchi et al., 2016 | ||
| vimentin | P08670 | 255-274 | Gln-Ile-Asp-Val-Asp-Val-Ser-Lys-Pro-Asp-Leu-Thr+Ala-Ala-Leu-Arg-Asp-Val-Arg-Gln | P | MS | Pro | Asp | Leu | Thr | Ala | Ala | Leu | Arg | Shinkai-Ouchi et al., 2016 | ||
| vimentin | P08670 | 255-274 | Gln-Ile-Asp-Val-Asp-Val-Ser-Lys-Pro-Asp-Leu+Thr-Ala-Ala-Leu-Arg-Asp-Val-Arg-Gln | P | MS | Lys | Pro | Asp | Leu | Thr | Ala | Ala | Leu | Shinkai-Ouchi et al., 2016 | ||
| vimentin | P08670 | 255-274 | Gln-Ile-Asp-Val-Asp-Val-Ser-Lys-Pro-Asp+Leu-Thr-Ala-Ala-Leu-Arg-Asp-Val-Arg-Gln | P | MS | Ser | Lys | Pro | Asp | Leu | Thr | Ala | Ala | Shinkai-Ouchi et al., 2016 | ||
| vimentin | Q5FWJ3 | 11-30 | Tyr-Arg-Arg-Met-Phe-Gly-Gly-Ser-Gly-Thr-Ser+Ser-Arg-Pro-Ser-Ser-Asn-Arg-Ser-Tyr | P | MS | Ser | Gly | Thr | Ser | Ser | Arg | Pro | Ser | Shinkai-Ouchi et al., 2016 | ||
| vimentin | Q5FWJ3 | 11-30 | Tyr-Arg-Arg-Met-Phe-Gly-Gly-Ser-Gly-Thr+Ser-Ser-Arg-Pro-Ser-Ser-Asn-Arg-Ser-Tyr | P | MS | Gly | Ser | Gly | Thr | Ser | Ser | Arg | Pro | Shinkai-Ouchi et al., 2016 | ||
| vimentin | Q5FWJ3 | 11-30 | Tyr-Arg-Arg-Met-Phe-Gly-Gly-Ser-Gly+Thr-Ser-Ser-Arg-Pro-Ser-Ser-Asn-Arg-Ser-Tyr | P | MS | Gly | Gly | Ser | Gly | Thr | Ser | Ser | Arg | Shinkai-Ouchi et al., 2016 | ||
| vimentin | Q5FWJ3 | 11-30 | Tyr-Arg-Arg-Met-Phe-Gly+Gly-Ser-Gly-Thr-Ser-Ser-Arg-Pro-Ser-Ser-Asn-Arg-Ser-Tyr | P | MS | Arg | Met | Phe | Gly | Gly | Ser | Gly | Thr | Shinkai-Ouchi et al., 2016 | ||
| vimentin | Q5FWJ3 | 11-30 | Tyr-Arg-Arg-Met-Phe+Gly-Gly-Ser-Gly-Thr-Ser-Ser-Arg-Pro-Ser-Ser-Asn-Arg-Ser-Tyr | P | MS | Arg | Arg | Met | Phe | Gly | Gly | Ser | Gly | Shinkai-Ouchi et al., 2016 | ||
| vimentin | Q5FWJ3 | 63-80 | Thr-Arg-Ser-Ser-Ala-Val-Arg-Leu-Arg+Ser-Ser-Val-Pro-Gly-Val-Arg-Leu-Leu | P | MS | Val | Arg | Leu | Arg | Ser | Ser | Val | Pro | Shinkai-Ouchi et al., 2016 | ||
| vimentin | Q5FWJ3 | 66-80 | Ser-Ala-Val-Arg-Leu-Arg-Ser-Ser-Val-Pro-Gly-Val-Arg+Leu-Leu | P | MS | Pro | Gly | Val | Arg | Leu | Leu | '-' | '-' | Shinkai-Ouchi et al., 2016 | ||
| vimentin | Q5FWJ3 | 65-80 | Ser-Ser-Ala-Val-Arg-Leu-Arg-Ser-Ser-Val-Pro-Gly-Val-Arg+Leu-Leu | P | MS | Pro | Gly | Val | Arg | Leu | Leu | '-' | '-' | Shinkai-Ouchi et al., 2016 | ||
| vimentin | Q5FWJ3 | 65-80 | Ser-Ser-Ala-Val-Arg-Leu-Arg+Ser-Ser-Val-Pro-Gly-Val-Arg-Leu-Leu | P | MS | Val | Arg | Leu | Arg | Ser | Ser | Val | Pro | Shinkai-Ouchi et al., 2016 | ||
| vimentin | Q5FWJ3 | 65-80 | Ser-Ser-Ala-Val-Arg-Leu-Arg+Ser-Ser-Val-Pro-Gly-Val-Arg-Leu-Leu | P | MS | Val | Arg | Leu | Arg | Ser | Ser | Val | Pro | Shinkai-Ouchi et al., 2016 | ||
| vimentin | Q5FWJ3 | 63-80 | Thr-Arg-Ser-Ser-Ala-Val-Arg-Leu-Arg+Ser-Ser-Val-Pro-Gly-Val-Arg-Leu-Leu | P | MS | Val | Arg | Leu | Arg | Ser | Ser | Val | Pro | Shinkai-Ouchi et al., 2016 | ||
| vimentin | Q5FWJ3 | 62-80 | Val-Thr-Arg-Ser-Ser-Ala-Val-Arg-Leu-Arg+Ser-Ser-Val-Pro-Gly-Val-Arg-Leu-Leu | P | MS | Val | Arg | Leu | Arg | Ser | Ser | Val | Pro | Shinkai-Ouchi et al., 2016 | ||
| vimentin | Q5FWJ3 | 62-80 | Val-Thr-Arg-Ser-Ser-Ala-Val-Arg-Leu+Arg-Ser-Ser-Val-Pro-Gly-Val-Arg-Leu-Leu | P | MS | Ala | Val | Arg | Leu | Arg | Ser | Ser | Val | Shinkai-Ouchi et al., 2016 | ||
| vimentin | Q5FWJ3 | 61-80 | Tyr-Val-Thr-Arg-Ser-Ser-Ala-Val-Arg-Leu-Arg-Ser-Ser-Val-Pro-Gly-Val-Arg+Leu-Leu | P | MS | Pro | Gly | Val | Arg | Leu | Leu | '-' | '-' | Shinkai-Ouchi et al., 2016 | ||
| vimentin | Q5FWJ3 | 61-80 | Tyr-Val-Thr-Arg-Ser-Ser-Ala-Val-Arg-Leu-Arg-Ser-Ser-Val-Pro-Gly-Val+Arg-Leu-Leu | P | MS | Val | Pro | Gly | Val | Arg | Leu | Leu | '-' | Shinkai-Ouchi et al., 2016 | ||
| vimentin | Q5FWJ3 | 61-80 | Tyr-Val-Thr-Arg-Ser-Ser-Ala-Val-Arg-Leu-Arg-Ser-Ser-Val+Pro-Gly-Val-Arg-Leu-Leu | P | MS | Arg | Ser | Ser | Val | Pro | Gly | Val | Arg | Shinkai-Ouchi et al., 2016 | ||
| vimentin | Q5FWJ3 | 61-80 | Tyr-Val-Thr-Arg-Ser-Ser-Ala-Val-Arg-Leu-Arg-Ser+Ser-Val-Pro-Gly-Val-Arg-Leu-Leu | P | MS | Arg | Leu | Arg | Ser | Ser | Val | Pro | Gly | Shinkai-Ouchi et al., 2016 | ||
| vimentin | Q5FWJ3 | 61-80 | Tyr-Val-Thr-Arg-Ser-Ser-Ala-Val-Arg-Leu-Arg+Ser-Ser-Val-Pro-Gly-Val-Arg-Leu-Leu | P | MS | Val | Arg | Leu | Arg | Ser | Ser | Val | Pro | Shinkai-Ouchi et al., 2016 | ||
| vimentin | Q5FWJ3 | 61-80 | Tyr-Val-Thr-Arg-Ser-Ser-Ala-Val-Arg-Leu+Arg-Ser-Ser-Val-Pro-Gly-Val-Arg-Leu-Leu | P | MS | Ala | Val | Arg | Leu | Arg | Ser | Ser | Val | Shinkai-Ouchi et al., 2016 | ||
| vimentin | Q5FWJ3 | 61-80 | Tyr-Val-Thr-Arg-Ser-Ser+Ala-Val-Arg-Leu-Arg-Ser-Ser-Val-Pro-Gly-Val-Arg-Leu-Leu | P | MS | Thr | Arg | Ser | Ser | Ala | Val | Arg | Leu | Shinkai-Ouchi et al., 2016 | ||
| vimentin | Q5FWJ3 | 61-80 | Tyr-Val-Thr-Arg-Ser+Ser-Ala-Val-Arg-Leu-Arg-Ser-Ser-Val-Pro-Gly-Val-Arg-Leu-Leu | P | MS | Val | Thr | Arg | Ser | Ser | Ala | Val | Arg | Shinkai-Ouchi et al., 2016 | ||
| vimentin | Q5FWJ3 | 61-80 | Tyr-Val-Thr-Arg+Ser-Ser-Ala-Val-Arg-Leu-Arg-Ser-Ser-Val-Pro-Gly-Val-Arg-Leu-Leu | P | MS | Tyr | Val | Thr | Arg | Ser | Ser | Ala | Val | Shinkai-Ouchi et al., 2016 | ||
| vimentin | Q5FWJ3 | 61-80 | Tyr-Val-Thr+Arg-Ser-Ser-Ala-Val-Arg-Leu-Arg-Ser-Ser-Val-Pro-Gly-Val-Arg-Leu-Leu | P | MS | '-' | Tyr | Val | Thr | Arg | Ser | Ser | Ala | Shinkai-Ouchi et al., 2016 | ||
| von Willebrand factor | P04275 | 754-773 | Ser-Ser-Pro-Leu-Ser-His-Arg-Ser-Lys-Arg-Ser-Leu-Ser+Cys-Arg-Pro-Pro-Met-Val-Lys | P | MS | Arg | Ser | Leu | Ser | Cys | Arg | Pro | Pro | Shinkai-Ouchi et al., 2016 |
